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Environmental estrogenic endocrine disruptors (EDs) are a health concern as the 
general population is exposed to a variety of EDs at low doses. Rapid screening and in 
depth understanding of how the body responds to EDs and their mixtures are crucial 
for toxicological evaluation and health protection. In this work, in vitro systems, 
including stable cells lines with estrogen induced green fluorescence protein (GFP) 
expression and micro cell culture analog (microCCA) devices, were developed to 
study EDs.  
 
A dual cell-line GFP expression system was constructed to study EDs with activities 
as estrogen receptor agonists or antagonists. The two stable cell lines, Ishikawa-GFP 
(uterine origin) and MCF7-GFP (breast origin), displayed increased intracellular GFP 
intensity with estrogens. This system also responded in a tissue specific manner to 
selective estrogen receptor modulators, raloxifene and tamoxifen. Our results also 
suggested no low dose synergistic effects between the tested estrogenic compounds.  
 
Physiologically realistic microCCA devices were developed to help predict in vivo 
responses to EDs.   The silicon microCCA device contained a co-culture of three cell 
lines: MCF7-GFP, Ishikawa-GFP and HepG2/C3A (liver origin). Recirculation of 
medium mimicked the time dependent changes in drug concentrations and the 
 microfluidic shear conditions inside a body.  An in-line bubble trap was incorporated 
into the system to overcome air bubble related device failure. Interactions between 
hydrophobic surfaces and the fluid were investigated. Significant surface adsorption of 
estrogen to polypropylene based tubing (BPT) was observed. Contaminants leaching 
out of the BPT tubing were also found to be estrogen receptor agonist. A pneumatic 
micropump with a pumping rate ~3 ul per min was build with PTFE tubing replacing 
BPT tubing. Detection of estrogens was demonstrated on a microCCA device 
integrated with the micropump.  
 
Further, a photopolymerizable hydrogel based method was developed for direct 
patterning of multiple types of cells into their individual cell culture chambers in a 
PDMS microCCA. The use of this device as a biosensor was demonstrated by 
monitoring PEG encapsulated cells in microCCA exposed to a model toxicant, Triton 
X-100. The results indicate the potential use of PDMS microCCA devices to study 
EDs. 
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CHAPTER 1* 
 
BACKGROUND AND INTRODUCTION 
 
1.1 In vitro cell co-culture systems  
In vitro cell culture has been an essential method in the study of the toxicology of 
drugs and environmental chemicals for many years.  However, traditional toxicity 
testing usually involves only one single type of cell dosed with one compound or a 
mixture of compounds. Results from such a test may be an incomplete prediction of in 
vivo response due to the absence of cell-cell and organ-organ interactions. The organs 
in the body have complex multicellular structures. The interactions between cells are 
critical for normal organ development and functions. Although organs are physically 
separated, they are interconnected by the blood circulation and communicate through 
secretion, absorption and metabolism of chemicals, including endocrine signals, into 
and from the blood stream. The existence of a second type of cell may alter the cell 
responses and functions. For example, co-culture of primary hepatocytes with non-
liver-derived endothelial or fibroblasts modulated the liver cell phenotype and specific 
functions [1]. Co-culture is a more physiologically realistic in vitro model for a living 
organism. In addition, as toxicological effects may be obvious in one kind of cell but 
not in another, identical tests are repeated with different cell types with only one type 
of cell each time. Such experiments are labor-intensive and time-consuming. Co-
culture, however, enables simultaneous monitoring on multi types of cells.  
 
 
 
1 Portions of this chapter have been published previously. Copyright 2007 from “Novel Cell Culture 
Systems: Nano and Microtechnology for Toxicology” by Michael L. Shuler and Hui Xu, In: Ekins S, 
editor. Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals. 
New York: John Wiley & Sons. p 693-724, 2007. 
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Figure 1.1 Illustration of multiple-type cell co-culture systems: (A) Random mixed; 
(B) Contact patterning with fuzzy boundaries; Co-culture without cell contact on (C) 
a flat surface or (D) in chambers; (E) the trans-well system and (F) the micro cell 
culture analog (microCCA) device. 
 
Cell co-culture can be realized in various ways. The following is a brief overview of 
these co-culture techniques used in biomedical applications. 
 
1.1.1 Randomly distributed cell co-culture 
Co-culture can be obtained by mixing multiple types of cells before cell seeding or by 
seeding one type of cell on top of another [2, 3], which results in random cell contact 
and distribution (Figure 1.1A). Change of cell seeding density or the ratio of cell 
population influences the strength of cell-cell interactions. In a mixed co-culture of 
Caco-2 cells and colorectal cancer HT29-5M21 cells, seeding ratios  influenced the 
paracellular permeability of  the cell monolayer [3]. In another study, adult rat 
hepatocytes maintained on top of a mesenchymal progenitor cell line C3H/10T1/2 
3 
 
cells [4]  or rat 3T3 fibroblast cells [5] maintained better viability and higher  
ethoxyresorufin O-dealkylase (EROD) activity and albumin secretion functions [5].  
 
Randomly distributed cell co-culture is simple in operation, but precise control of cell-
cell contact and interactions is difficult.  In addition, in many cases it might be 
difficult to differentiate cell type A apart from type B.  
 
1.1.2 Co-culture with fuzzy boundaries 
Nano and microfabrication techniques allow organized patterning of two or more 
types of cells in contact with defined boundaries, which may become less distinct after 
cell spreading and growth (Figure 1.1B). Bhatia et al. patterned on glass several stripes 
of liver and fibroblast cells next to each other using photolithography [6]. Primary rat 
liver cells were patterned based on surface modification with aminosilanes linked to 
biomolecules, and 3T3-J2 fibroblasts were attached to the remaining unmodified area 
through non-specific, serum mediated attachment. Using the same approach, 
hepatocytes were patterned into round isolated islands while fibroblasts filled the 
spaces between liver cells [2]. The influence of direct contact on cell functions can be 
studied by correlating cell function with the distance to the point of direct contact. 
Induction of hepatic functions in hepatocytes was observed to increase in the vicinity 
of fibroblasts and maximal induction of liver-specific functions was correlated with 
maximal initial heterotypic interaction [2]. It was suggested that heterotypic cell 
contact is necessary for induction of these functions [7]. This technique also enables 
control over the strength of cell-cell interaction without changing the numbers of each 
type of cells. But one limit of this method is that with time motile and mitotic cells 
will eventually intermix and the relative cell numbers can change [6]. 
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1.1.3 Co-culture without cell contact 
If the subject of interest is soluble chemical signals in the culture medium, a no-
contact cell co-culture system is preferred to eliminate the potential influence through 
direct contact. By increasing the distance between patterned cell stripes (Figure 1. 1C), 
Bhatia et al. was able to keep the cells well separated  to study how the space between 
co-culture cells affects their interactions [1]. Cells can also be separated by being 
confined to certain regions by physical barriers such as deep chambers or straight 
walls. Li et al. developed an integrated discrete multi-organ cell culture system 
(IdMOC) [8], which is a cell culture plate with relatively large wells subdivided into 
small subcompartments (Figure 1.1D). The IdMOC plates were modified from six-
well tissue culture plates with seven inner wells of a diameter of 8 mm, a height of 0.8 
mm and a capacity of 100 ul. Cells from multiple organs were cultured separately in 
small wells within one big well. For toxicity testing, drug-containing medium was 
added to flood all inner wells, thus all cells were exposed to the same medium and 
communications between cells was allowed. But the cells do not physically contact 
each other.  
 
The transwell (Figure 1.1E) or other membrane-based methods also enable isolated 
cell co-cultures. Membrane filters, with a pore size from 0.1 um to 12 um are used as 
cell growth substrates. Generally one type of cell is seeded onto the membrane with a 
second type of cells cultured on the bottom of the well.  
 
1.1.4 The cell culture analog 
Although the cell culture systems described above enable the observation of some 
cell-cell and “organ-organ” interactions, the gap between in vitro and in vivo testing is 
still wide.  In those systems, the fluid to cell volume ratio and the relative size of each 
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‘organ’ are far from their physiological values. In addition, all of these cell culture 
systems are static while cells in the body experience a more dynamic environment, 
with blood circulation replenishing nutrition, carrying away waste, transporting 
chemical signals generated in one cell to other cells, and exerting necessary 
mechanical forces for cell growth and differentiation. 
 
The cell culture analog (CCA) system is one approach that attempts to bridge this gap. 
The design of the CCA is guided by physiologically based pharmacokinetic (PBPK) 
modeling. A PBPK is a mathematical model for predicting the overall plasma and 
tissue kinetic behaviors based on available data on physicochemical properties and 
specific absorption, distribution, metabolism, and elimination (ADME) processes [9].  
In its design, the fluid fraction feeding each cell culture chamber is the same as the 
blood fraction received by the corresponding organ in vivo. Plus, the fluid residence 
time in each chamber equals its in vivo value. The liquid to cell ratio in each cell 
culture unit is managed to be as close as possible to its physiological value (about 0.5). 
Shear stress introduced by the flow is calculated and is kept at the physiological level 
for that type of tissue. A CCA device can be considered as a simplified and minimized 
human/animal body, in which mammalian cell cultures are used to represent key 
functions of specific organs, with cell culture medium being used as a blood surrogate.  
 
The CCA was first developed and applied to study the toxicology of naphthalene in 
rats [10]. A microCCA is a miniature version of the macroscopic CCA. It achieves 
more physiologically realistic liquid-to-cell ratios in tissue compartments than the 
macro CCA. A typical microCCA chip is fabricated using the standard 
photolithography method [11] in a silicon chip 2.5 cm x 2.5 cm in size, with small 
chambers replacing big flasks for cell culture (Figure 1.1F).  The microCCA allows in 
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situ monitoring of the physiological status of cells and chemical bioaccumulation. The 
first version of microCCA devices were designed based on the same PBPK model 
used for the macro CCA, and succeeded in predicting  the toxicity of naphthalene on 
lung cells [11, 12] and to study the multi drug resistance [13].  
 
In chapter four, a microCCA was designed and fabricated for studying environmental 
estrogenic endocrine disruptors and antiestrogens. Three types of human carcinoma 
cell culture of the liver, mammary tissue and the endometrial tissue were co-cultured 
on a one inch square silicon chip.  This device allowed simultaneous monitoring of 
estrogenic responses from all cell lines. Tissue specific effects of selective estrogen 
receptor modulators (SERMs) were also observed.  
 
1.2 Micro and nano fabrication technique for micro cell culture devices  
The integration of modern nano and microfabrication technologies with cell culture 
has contributed to the development of new devices for toxicological studies and drug 
evaluations [14, 15]. Minimization of cell culture devices lowers the device cost, 
decreases chemical usage and waste production, allows massively parallel tests, and 
most importantly, provides opportunities for researchers to control, monitor and 
analyze cell responses with few cells, or even at the single-cell or subcellular level 
[16]. Nano and micro techniques enable manipulations, with nano and micrometer 
control, on the biochemical composition and topology of the substrate, the medium 
composition, and the cellular microenvironment [17], which results in an improved 
mimic of the extracellular microenvironment a cell experiences in vivo,  and brings in 
vitro cell responses closer to in vivo cell responses. Miniature cell-based biosensors 
have been quickly developed for the functional characterization and detection of a 
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wide range of biologically active compounds, including drugs, pathogens, toxicants 
and odorants [14].  
 
Nano and microfabrication technologies have been widely used in biological studies 
which combine microfluidics and cell handling for microreactors, cell culture, cell 
stimulation, cell sorting, cell lysis, sample separation, purification, and biochemical 
analysis [14]. These techniques are capable of fabricating miniature devices for cell 
culture with specific, pre-designed patterns, and for biochemical analysis with 
incorporated optical and electrical components. The following is a brief overview of 
some of the fabrication techniques, including photolithography, electro-beam 
lithography, soft lithography, hot embossing and laser micromachining (Figure 1.2) 
with a discussion on their strengths and weaknesses.  
 
1.2.1 Photolithography 
Borrowed from the semiconductor industry, photolithography has been well accepted 
for patterning cells and fabricating micro featured bio-microfluidic devices on silicon 
and glass substrates [18, 19]. The resolution of photolithography is limited by the 
optical diffraction, with a minimum feature size around 50 nm [18]. The first step is to 
generate photo-masks with the desired patterns by direct laser or ultraviolat (UV) light 
“pattern writing” onto the thin photo-resist layer on a chrome (Cr) coated glass or 
quartz plate (Figure 1.2). To transfer this pattern onto a silicon or glass substrate, the 
substrate is spin-coated with photoresist and exposed to ultraviolet light through the 
mask, which selectively allows light through. The exposed photoresist will be either 
solubilized (positive-tone photoresist) or crosslinked (negative-tone photoresist), 
followed by exposure to a developer solution which removes solubilized or un-
crosslinked photoresist, and results in a photoresist pattern. This pattern can be used 
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for direct biomolecular (such as cell adhesion molecules for cell attachment) 
deposition [1], or for selective dry or wet etching into the substrates to form chambers 
for cell placement and fluid handling [12]. The remaining photoresist can then be 
dissolved in acetone or resist remover or etched off by plasma stripping.  
 
The application of photolithography, however, is limited by its requirement for 
expensive facilities, high processing cost and limited resolution.   
 
 
 
1.2.2 Electro-beam (E-beam) lithography  
Electro-beam lithography has been the primary technique for defining, patterning and 
connecting experimental structures at the nanoscale [20]. E-beam lithography uses a 
Figure 1.2 Schematics of typical nano and micro fabrication techniques: 
Photolithography, soft lithography, hot embossing and direct writing.
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narrow electron beam to generate patterns. The extremely short quantum mechanical 
wavelength of high energy electrons allows it to overcome the diffraction limit, 
creating single surface features about 3-5 nm in size. This limit increases to 30-40 nm 
for large area surface patterning [18, 21, 22]. E-beam lithography allows computer-
controlled direct pattern writing onto resist-coated substrates without an expensive 
physical mask. It has some drawbacks as well, such as its high initial capital expense, 
and slow writing speed due to its point-by-point exposure method.  
 
1.2.3 Soft lithography 
Soft lithography is developed for the fabrication of relatively large microstructures (> 
50 um) in biological applications [23, 24]. It represents a group of surface patterning 
techniques including the micro contact printing, microfluidic patterning, and stencil 
patterning. One key feature of soft lithography is the use of elastomeric materials, 
most commonly poly (dimethylsiloxane) (PDMS), to replicate patterns from a master 
by molding. PDMS is inexpensive, biocompatible, highly gas permeable, amenable to 
surface modification, and optically transparent [25]. Soft lithography enables high 
volume production of disposable devices and lowers the cost for frequent design 
changes common in biological research. 
  
Soft lithography starts with making masters for PDMS molding. The master can be 
either a silicon master or a SU-8 mold made from photolithography, with SU-8 mold 
being the more popular choice. SU-8 is a transparent negative-tone photoresist 
originally designed for the MEMS industry. It features a high aspect ratio, good 
mechanical strength, excellent chemical resistance, biocompatibility and low cost. The 
process of making a SU-8 mold is simple: spin coat, expose, and develop. To mold 
PDMS devices, the PDMS oligomer and crosslinking prepolymer are mixed well and 
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poured onto the SU-8 mold. Negative pressure is applied for removal of air bubbles 
introduced by mixing. The PDMS precursor mixture is allowed to cure at 65˚C 
overnight, after which the PDMS sheet can then be peeled off the mold. This micro 
featured PDMS slab is then ready for use as a stamp for micro contact printing or can 
be sealed against a substrate for microfluidic applications. 
 
Micro contact printing (uCP) uses a PDMS stamp to pattern chemical molecules, such 
as  proteins or alkanethiolates, onto silicon, glass, gold [26], PDMS [27] and many 
other plastic substrates. Proteins are deposited or passively absorbed onto the PDMS 
stamp then brought into contact with the substrate surface for several minutes. Upon 
lifting of the stamp, the protein pattern is left on the surface. Printing of cell adhesive 
proteins will result in cell attachment only at defined areas. uCP  is capable of 
transferring patterns with features of 1 um dimensions and with an edge roughness of 
< 100 nm [23]. This resolution is limited by the stamp distortion during its contact 
with the substrate, and the surface diffusion of low molecular weight inks [28].  
 
Microfluidic patterning combines a channel system with laminar flow to deliver 
chemical molecules in solution or cells in suspension to a restricted area. When a 
PDMS sheet with features is sealed to a glass slide, water-tight flow pathways are 
formed. This seal is reversible. Proteins or cells can be patterned onto the glass slide 
by forcing the solution flow through these fluidic channels. It should be noted that the 
laminar flow in microscale channels allows patterning of several different fluids in 
parallel to each other in one channel [18]. This phenomenon is also used for gradient 
generation and toxicological assessment, which are further explained later in this 
chapter. 
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Stencil patterning of cells utilizes a thin piece of PDMS sheet with through holes 
(stencil) to confine protein solution or cell suspensions within defined boundaries.  
The stencil works as a physical barrier to avoid contact of cell or protein solution with 
the substrate except at open areas in the stencil. With multi openings on the stencil, 
multi types of cells can be seeded onto the same piece of substrate for co-cultures. 
Stencils can be made out of other biocompatible materials as well, but a good seal 
between the stencil and the substrate is required to avoid cell or chemical cross-
contamination.  
 
1.2.4 Hot embossing  
Hot embossing is also called thermal imprinting. This technique is capable of 
manufacturing features in the thermoplastic polymers with dimensions as small as 10 
nm [29]. Hot embossing is capable of manufacturing microfeatures with polymer 
substrates such as polymethyl methacrylate (PMMA) [30], polycarbonate, cyclo-olefin 
copolymer (COC) [31] and polyimide [29]. For embossing, a silicon or hard polymer 
mold is pressed into thermoplastic materials at a temperature higher than the 
material’s glass transition temperature (Tg), forming a relief of its feature in the 
plastic. The material surface is textured and separated from the mold once the polymer 
is cooled below the Tg [28]. The major advantages of hot embossing include its very 
low cost, capability for volume production of disposable devices,  and ability to form 
3D features that are difficult to produce in silicon [29].  
 
1.2.5 Laser micromachining 
Lasers can be used for both laser ablation and laser polymerization. Laser ablation 
combines evaporation and melt expulsion to remove metals, ceramics [32], glass, 
silicon and plastics materials, while laser polymerization builds three-dimensional 
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microstructures through laser induced polymerization of organic-inorganic hybrid 
biomaterials [33]. Laser ablation can produce surface features in the 5-500 um range 
with submicron accuracy [34].  Coupled with a microlithographic projection 
technique, laser micromachining with a metal mask can generate fine microstructures 
at the micron and submicron level by focusing the laser beam exiting the mask onto 
the polymer target surface via an optical setup for a reduction of the mask pattern [34, 
35]. The high-relief topology of the laser lithographed substrates can also be utilized 
as a master/mold for PDMS stamps for microcontact printing and spatial patterning of 
cell adhesion proteins. 
 
Multiphoton absorption is a non-linear optical phenomenon where two or more low 
energy photons are absorbed instead of a high energy photon [36]. Since this process 
requires an intense flux of excitation photons, optical absorption, and consequent laser 
ablation or polymerization, are tightly confined to the vicinity of focus with a 
micrometer resolution [37]. Using this technique, Giridhar et al were able to drill a 
subsurface tunnel into glass substrate with a high power femtosecond pulsed laser. 
Multiphoton absorption induced polymerization of organic-inorganic hybrid 
biomaterials is also used to fabricate microscopic 3D topographies, such as barriers 
and growth lanes, and microstructured medical devices [33]. Polymerization can be 
done  in situ within dissociated neuron cell cultures without compromising cell 
viability [38]. In a different application,  Costantino and coworkers added fluorescent 
dyes to UV-cured resins and used two-photon optical lithography to make spatial 
landmarks to quantify molecular transport, cell growth and migration [39].  
 
Laser micromachining is automatic, fast, cheaper than hot  embossing [40], and is 
capable of causing no or very little thermal effects and allows a very clean cut surface 
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[35]. The direct writing of subsurface features with multi-photon absorption is unique 
among available nano and micro fabrication methods.  
 
1.3 Materials for miniature cell culture devices 
Design considerations in material selection for a miniature cell culture system may 
include biocompatibility, capability for surface modification that allow cell 
attachment, chemical resistance to working fluids, ease of fabrication or processing, 
durability, and cost. 
 
Silicon and glass are traditional substrates used for micro and nanofabrication. 
However, they are fragile, and the processes for patterning silicon and glass surfaces, 
such as photolithography and E-beam lithography, are expensive. Many ceramics, 
such as Titania ceramic (Titanium Dioxide), are very biocompatible implant materials 
and can be easily shaped by molding [41]. Gold or gold-coated substrates are often 
used for cell culture in cell-based biosensors for easy detection of electrical signals 
[42]. Titanium alloy is a material with good biocompatibility, but poor machinability 
[43]. Nature and synthetic polymers, especially plastics, are the most popular material 
for fabricating cell culture devices. Plastics are usually durable, optically transparent, 
relatively inexpensive, and thus suitable for disposable biomedical devices. They can 
be micro-machined by soft lithography, hot embossing, direct laser machining and 
other techniques. Flexible plastic substrates used in soft lithography include PDMS, 
poly(ethylene-dioxythiophene)/polystyrene sulfonate (PEDT/PSS) [44], polymeric 
films. Polystyrene, PMMA, polycarbonate, Plexiglas®, and polyethylene are the 
common plastics used for fabricating cell culture devices using hot embossing. 
Plastics are seldom used in photolithography due to the difficulty to achieve a good 
contact between mask and the substrate.  It should be noted that surface modification 
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to promote cell adhesion on the surface of all these materials is usually required to 
support cell proliferation and function. 
 
Materials used for three dimensional cell cultures within micro cell culture devices 
have different requirements for physical properties (such as mechanical strength), as 
well as chemical properties. There are two types of biomaterial for 3D cell culture, 
porous polymers and hydrogels. Porous polymers such as polylactic acid (PLA), 
polyglycolic acid (PGA), poly (lactic-co-glycolic acid) (PLGA) are constructed with 
various pore sizes to house cell cultures. Hydrogels are three-dimensionally cross-
linked macromolecules of hydrophilic polymers. They are soft in texture and easy to 
handle at microliter scale. "Naturally based" hydrogels such as Matrigel (made of 
native extracellular matrix proteins), collagen (the major extracellular matrix protein) 
and hyaluronic acid provide endogenous signals that promote the cellular interactions 
that underlie tissue formation. Hydrogels to mimic the extracellular matrix can be 
created from synthetic molecules such as poly (ethylene glycol), polyglycolide, 
polylactide, acrylamide derivatives, calcium alginate and agarose, [45, 46]. These 
polymers are cross-linked using ultraviolet ray, radioactive ray, chemical cross-linking 
agent, ion solutions, or via temperature control for thermo-responsive hydrogels to 
reach a three-dimensional form. The advantages of synthetic gels include their 
consistent composition and predictable manipulation of properties, but they lack 
functional sites to interact with soluble or cell-surface proteins [47]. Proteins and 
positive charged components are often added into the composition to support cell-gel 
interactions. Cells are usually incubated within the polymer during this process and 
remain encapsulated after the gel is formed.  
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Table 1.1 Examples of potential endocrine disruptors 
 
 
1.4 Biological problem of interest: estrogenic endocrine disruptors 
Endocrine disruptors (EDs) are environmental or man-made xenobiotic chemicals that 
are hormonally active They might disrupt the endocrine system of humans and the  
wildlife [66]. EDs affect a variety of biochemical and physiological processes that are 
regulated by critical hormonal signaling systems. Consequences of ED action may 
include disruption of normal sexual differentiation, sexual maturation, gonad function, 
reproduction, metabolism, digestion, and growth. In laboratory studies EDs caused 
developmental and reproductive problems in animals, fish and other wildlife [66]. 
However, their impact on human beings is still unclear due to limited human studies. 
Recent research showed that prenatal phthalate exposure at environmental levels can 
adversely affect male reproductive development in humans, with a decrease in 
Organochlorines Dichlorodiphenyltrichloroethane (DDT) [48] 
DDE (derivatives Of DDT) [49] 
Dieldrin [50] 
Methoxychlor (MXC) [51] 
Industrial Chemical Polychlorobiphenyls (PCBs) [52] 
Brominated Diphenylether (PBDP) [53] 
Trichlorobenzene (TCB, fabrics Additives) [54] 
Phthalate Esters [55] 
2-hydroxy-4-methoxy-benzophenone (HMBP,  
photostabilizer) [56] 
2,2-dimethoxy-2-phenyl-acetophenone (DMPA,  
photoinitiator) [56] 
Industrial Contaminants Dioxin-TCDD[57, 58] 
Food Additives Butylated Hydroxyanisole (BHA) [59] 
Butylated Hydroxytoluene (BHT, inhibitor) [59] 
Herbal Estrogens Daidzein [60] 
Genistein [61, 62] 
Lignans [63] 
Heavy Metals Cadmium [64] 
Arsenic [65] 
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anogenital distance among male infants [67]. But such results were usually doubted 
and considered as “not conclusive” due to small number of subjects. 
 
Human and environmental exposure to EDs, however, is undoubtly occurring with the 
widespread accumulation of ED chemicals in the environment. The list of chemicals 
that could act as EDs is extensively long. Table 1.1 summarizes a very small portion of 
this list with compounds that have been proven to interact with estrogen receptors. In 
addition, most EDs (such as DDT and PCBs) are persistent and refractory with slow 
transformation and degradation in the body as well as in the environment. They tend to 
be retained in the body and environment for decades. As the chemicals bio-accumulate 
in the body through diet and environmental exposure, their effects are consequently 
bio-amplified. It is important to point out that endocrine disruption can occur at levels 
far lower than those normally associated with toxicants. And these different chemicals 
at very low level may act together or modulate each other, resulting in synergistic 
effects [68].  There has been uncertainty and concerns about the health risks associated 
with both general population exposure and occupational exposure to a variety of EDs 
at various levels.  On the other hand, the adverse effects of EDs are not obvious, 
advance slowly, and may take several generations to be observed and diagnosed. It is 
necessary to promote public awareness of the risk of EDs exposure. Production and 
disposal of potential EDs should also be monitored and regulated. 
 
The Congress of the United States passed the Food Quality Protection Act in 1996, 
requiring that Environmental Protection Agency (EPA) initiate Endocrine Disruptor 
Screening Program (EDSP) to screen pesticide chemicals and environmental 
contaminants for their potential endocrine disrupting capabilities. The progress of the 
EDSP, however, is slow, partially due to the lack of standard methods and procedures 
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for evaluating a chemical’s endocrine disrupting impacts. Currently, there are no 
standardized approaches for determining whether a particular compound has ED 
activity. In vivo animal models are perhaps the best approaches available, but they are 
expensive, time consuming, and fail to produce direct insights into the molecular basis 
of ED action.  Furthermore, it is not always possible to accurately predict human 
responses from animal models.  Though these in vitro studies can give useful data, 
they may not provide conclusive information about the response in living animals. For 
example, the active compound may be a metabolite which may not be present in many 
in vitro assays [69].  
 
This thesis will describe the development in vitro systems to study the toxicity of 
estrogenic endocrine disruptors. Chapter two describes the creation of a stable dual 
cell-line green fluorescence protein (GFP) expression system, and the application of 
this system to detect EDs and to evaluate possible synergistic effects between EDs. 
This system is capable of addressing tissue specific effects in mammary and 
endometrial cultures to estrogenic EDs, selective estrogen receptor modulators 
(SERMs) and antiestrogens. Chapter three describes the discovery of endocrine 
disrupting contaminates from plastic tubing used in microfluidic cell culture systems. 
Surface modification and coatings were tested for their effect on contaminant 
leaching, as well as chemical loss due to surface adsorption. To overcome such 
problems, in chapter four, a peristaltic micropump was developed to drive the 
recirculation fluid flow instead of the traditional peristaltic pump which often uses a 
significant length of plastic tubing. The fabrication of a silicon based microCCA, a 
physiologically related cell co-culture device, with standard photolithography is also 
described in chapter four. Results from microCCA device to study EDs and 
antiestrogens are presented. Chapter five describes a disposable PDMS microCCA 
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setup with 3D cell culture within hydrogels, which is more physiologically realistic 
than traditional 2D cell cultures. The photo-curable nature of Poly (ethylene glycol) 
(PEG) hydrogels is an innovational approach to pattern multi-type of cells within a 
closed cell culture system. Finally, the overall results of this project is summarized and 
discussed, with suggestions and recommendations for future work presented and 
evaluated. 
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CHAPTER 2* 
 
DEVELOPMENT OF A STABLE DUAL CELL-LINE GFP EXPRESSION 
SYSTEM TO STUDY ESTROGENIC ENDOCRINE DISRUPTORS 
 
2.1 Abstract 
Environmental estrogenic endocrine disruptors are a health concern. Here we 
constructed a dual cell-line green fluorescence protein (GFP) expression system to 
identify and study endocrine disrupting compounds with activities of estrogen receptor 
agonists or antagonists. Human breast cancer MCF-7 cells and endometrial carcinoma 
Ishikawa cells were infected with a two tandem estrogen response elements–E4 
promoter-GFP reporter gene construct. The use of GFP reporter enabled direct and 
simple evaluations of cell responses. GFP intensity in stably transfected MCF7-GFP 
and Ishikawa-GFP cells was dose-responsive to 17-beta-estradiol, diethylstilbestrol, 2-
hydroxyestradiol, and environmental toxins bisphenol A, genistein and o-p'-DDT. 
Raloxifene and tamoxifen were effective antiestrogens in MCF7-GFP cells, but acted 
as partial estrogen receptor agonists in Ishikawa-GFP cells at concentrations of 0.1 nM 
and above. No synergistic effect was observed in chemical combinations between 
organochlorine pesticides methoxychlor, o-p'-DDT, p-p'-DDT, nor between estradiol 
and estrone. In summary, for the first time the effects of estrogen receptor agonists or 
antagonists were compared between mammary and endometrial cancer cells both 
stably expressing identical plasmids with GFP reporter genes under the control of 
tandem estrogen response elements. This dual cell-line system provides a rapid   
 
 
1 This chapter is based on “Development Of A Stable Dual Cell-Line GFP Expression System To Study 
Estrogenic Endocrine Disruptors” by Hui Xu, W. Lee Kraus, and Michael L. Shuler, Biotechnol Bioeng 
101(6):1276-1287, 2008 
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method and sensitive assay to identify environmental estrogens, antiestrogens, 
selective estrogen receptor modulators and to study their tissue specific effects and 
chemical interactions. Such a system is especially useful for direct and parallel toxicity 
assessments with a microfluidic cell culture device. 
 
2.2 Background and introduction 
Since the last decade, there has been growing concerns that estrogenic pollutants in the 
environment, such as dichlorodiphenyltrichloroethane (DDT) and bisphenol A (BPA), 
may mimic natural hormone estrogens, interfere with the normal endocrine system, 
and elicit adverse health issues in both humans and wildlife [1].  Exposure to 
estrogenic endocrine disruptor (ED) chemicals in humans may adversely influence 
female fecundity and fertility, cause developmental and reproductive diseases, and 
increases the incidence of estrogen-related cancers [2-4]. These concerns have been 
heightened by the possibility that mixtures of weak EDs may exhibit complex 
synergistic interactions [5]. Examples of known environmental EDs include pesticides 
DDT, methoxychlor (MXC) [6, 7], plasticizers such as phthalate esters and BPA [8-10], 
food antioxidants butylated hydroxyanisole (BHA) [11], and herbal estrogens such as 
genistein and daidzein in various beans. 
            
Estrogens are essential hormones in regulating the development and functions of the 
reproduction, nervous, skeletal and the cardiovascular systems. Long-term estrogen 
signaling occurs primarily through the direct binding of liganded estrogen receptors 
(ERs) to specific DNA sequences in the genome (estrogen response elements, or EREs) 
or the indirect binding via interactions with other classes of DNA bound transcription 
factors, such as activating protein 1 (AP1) [12-14]. This binding consequently recruits 
co-activators and modulates transcription of downstream target genes that regulate cell 
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proliferation, energy production and survival [12, 14]. The actions of estrogen vary in 
different target tissues.  
 
A variety of in vivo and in vitro assays and in silico models have been developed in 
these years for screening of potential ED compounds and their mixtures. 
Environmental assays examine fish gonadal recrudescence and frog metamorphosis 
[15]. Rodent uterotrophic assays determine growth of the uterus gravimetrically [16], 
and the multigenerational tests assesses long-term toxicity of pollutants [17].  
However, in vivo animal assays are costly and time consuming. It is also difficult to 
extrapolate human responses accurately from animal models. Computational tools, 
such as the nuclear receptor quantitative structure–activity relationship (QSAR) [18] 
and molecular docking [19, 20], attempt to predict endocrine disrupting activities 
basing on chemical structures. But the predictability of such tools is constrained by the 
limited structural similarity of estrogenic EDs. And predictions derived from 
computational analysis still require conventional bioassays to verify or obtain the 
results. 
 
Recently DNA microarrays have been used to recognize the pattern of gene 
transcription in target cells stimulated by estrogens, which is then used to identify 
potential estrogenic compounds [21-23]. However, microarray requires careful sample 
preparation and hybridization, as well as complex data analysis. Hormone receptor 
binding assays measure the affinity of a compound to ER, but provide no specific 
information about its agonist or antagonist effects. Cell proliferation test (E-Screen) 
identify estrogenic chemicals by their proliferative effects,  yet it suffers from lack of 
specificity [24], lengthy test times (5 to 6 days) and inability to produce direct insights 
into the molecular basis of chemical toxicity.  
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Methods employing reporter gene expression systems for estrogenicity measurements 
are typically fast and sensitive [25]. Yeast-based assays are simple, yet only provide 
limited information about responses in human cells. In human cell line based assays, 
luciferase (Luc) [25, 26] or chloramphenicol acetyltransferase (CAT) [27] reporter 
genes offer significant sensitivity. However, quantification of enzyme activities 
requires cell lysis and addition of enzyme substrates, which are costly and difficult to 
perform on microfluidic cell culture devices. Green fluorescence protein (GFP) is a 
real time quantitative reporter with high levels of brightness and photostability [28]. It 
allows easy and direct quantification with a fluorescence microscope or a 
spectrofluorometer. GFP can be introduced into target cells by transient or stable 
transfection. Transient transfection based assays require repeated cell transfection 
before each assay, while stably transfected cell lines, on the other hand, are ready to 
use, cost effective, and generate more consistent results.  
 
The effects of estrogens and antiestrogens are tissue specific [29]. Mammary tissue 
and endometrial tissue are the main targets of estrogens. However, their responses to 
EDs haven’t been compared side by side in a transcription assay with stably 
transfected cell lines. Only a few stably transfected human mammary cell lines have 
been reported. Most of them used Luc or CAT as reporters.  The only two reported cell 
lines using GFP as the reporter [9, 30], however, are not readily available.  
 
Our motivation for this work arises from a novel in vitro system, termed as microscale 
cell culture analog (microCCA), to evaluate the efficacy and toxicity of potential 
pharmaceuticals and environmental toxins [31-33]. The device is 2.5 cm x 2.5 cm in 
size on a silicon wafer. Multiple human cell lines, such as the mammary, endometrial, 
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liver cells and fat cells, can be cultured on the device in separate yet interconnected 
organ chambers. Cell culture medium (200 ul) is re-circulated through them as a blood 
surrogate. The physical microCCA system is a direct analog to a Physiologically 
Based Pharmacokinetic (PBPK) modeling [34]. Chamber size is calculated to provide 
liquid residence time similar to that in the tissue or organ. Reaction rates in flow 
limited models are determined by residence time. The relative size of compartments is 
set by the ratio of organ sizes. MicroCCA provides a more physiology-related 
dynamic environment for assessments of chemical toxicity in multiple cell lines 
simultaneously. It is developed to address the issues of reactive metabolite formation 
and tissue-tissue interaction through exchange of metabolites. The MicroCCA is a 
relatively complex system compared to traditional cell cultures due to its compact size, 
multi types of cell culture and the microfluidic system. Because of the difficulty to 
dislodge cells and separate them from one population from another, on-chip 
quantification of Luc/CAT activities in each individual type of cells is inconvenient. 
Instead, cell lines with estrogen-stimulated GFP expressions are preferred. While such 
cell lines may be used in a microCCA, they can be used advantageously in other assay 
systems such as multiwall, static cultures. 
 
We report here the development of two stably transfected GFP reporter cell lines, 
MCF7-GFP and Ishikawa-GFP, to detect, quantify and study estrogenic and 
antiestrogenic compounds. The parent cell lines are MCF7-BOS [35, 36], a subline of 
MCF-7 human breast cancer cell line, and Ishikawa [37, 38], an endometrial 
adenocarcinoma cell line.  We investigated how these cells respond to 17β-estradiol 
(E2), natural and synthetic hormones, pesticides and their mixtures, and how steroid 
starvation affects such responses. In addition, we examined the tissue-specific effects 
of several known antiestrogens. Our results indicated that both cell lines responded 
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promptly and specifically to estrogenic chemicals. Although tamoxifen and raloxifene 
acted as ER antagonists in MCF7-GFP cells, they both exhibited ER-mediated 
estrogenic activity in Ishikawa-GFP cells. Finally, no synergistic interaction was 
observed between tested weak estrogenic chemicals. The dual cell-line system 
provides a fast, direct and high throughput method to identify ER agonists, antagonists 
or selective ER modulators (SERMs), as well as to study possible chemical 
interactions between them. 
 
2.3 Materials and methods 
2.3.1 Chemicals and reagents  
E2, estrone (E1), 2-hydroxyestradiol (2-OHE2), Bisphenol A (BPA), ICI 182,780 
(Fulvestrant, ICI), 4-hydroxy tamoxifen (Tam), raloxifene hydrochloride (Ral), 
methoxychlor (MXC), genistein (GEN), diethylstilbestrol (DES), o-p'-DDT, p-p'-DDT, 
puromycin, and polybrene were purchased from Sigma (St. Louis, MO).  Fetal bovine 
serum (FBS) and charcoal-dextran stripped fetal bovine serum (CDFBS) with reduced 
steroid levels were from Hyclone (Logan, UT). FuGene 6® transfection reagent was 
from Roche Applied Science (Indianapolis, IN). 
 
2.3.2 Cell culture  
MCF7-BOS cells were kindly provided by Dr. Ana Soto and Dr. Carlos Sonnenschein 
(Tufts University School of Medicine, Boston, MA). These cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (MP Biomedicals, Solon, OH) 
supplemented with 5% heat inactivated FBS. Heat inactivated FBS was prepared by 
heating FBS in a 57℃ water bath for 30 minutes followed by a filtration through a 
0.2-micron filter. 293T, an adenoviral transformed human embryonic kidney cell line, 
was a generous gift from Dr. Volker Vogt (Cornell University, Ithaca, NY). These cells 
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were maintained in DMEM medium (Sigma, St. Louis, MO) supplemented with 10% 
FBS. Ishikawa cells were a kind gift from Dr. Myles Brown (Dana-Farber Cancer 
Institute, Boston, MA). Cells have been maintained in Minimum Essential Medium 
(MEM) (Invitrogen, Carlsbad, CA) with 10% FBS.  All the cells were cultured at 37°C 
in a humidified, 5% CO2, 95% atmosphere incubator. 
 
 
 
 
Figure 2.1 Schematic representation of the puromycin-resistant GFP reporter plasmid 
pQCXIP-2ERE-GFP. In a retrovirus vector pQCXIP-GFP containing a cDNA 
sequence encoding enhanced GFP, the immediate early CMV promoter (PCMV IE) was 
replaced with two tandem estrogen response elements (EREs) upstream of an 
adenovirus E4 core promoter. 
 
2.3.3 Plasmid construction  
The consensus ERE is a 13 base pair inverted repeat sequence (GGTCANNNTGACC) 
[12, 39]. The retrovirus vector pQCXIP-GFP containing a cDNA sequence encoding 
enhanced GFP was provided by Dr. Volker Vogt (Cornell University, Ithaca, NY). This 
plasmid contains a puromycin resistance gene (Purr). The immediate early CMV 
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promoter (PCMV IE) was removed from pQCXIP-GFP with restriction enzymes BglII 
and NotI digestion and a fragment containing two tandem EREs and the adenovirus E4 
core promoter was ligated in place. The ligation product was pQCXIP-2ERE-GFP 
(Figure 2.1). 
 
2.3.4 Retrovirus infection of MCF7-BOS and Ishikawa cells    
Retrovirus infection was performed by modifying the protocol described by Pear and 
coworkers [40]. 293T were used as the packaging cell line. 293T cells were cultured in 
6 well plates to reach ～80% confluence.  Cells were transfected with the plasmid 
pQCXIP-2ERE-GFP using FuGene 6® transfection reagent. The retroviral supernatant 
was then harvested 48 h post transfection and filtered through a 0.45 um filter to 
remove living cells. To infect MCF7-BOS or Ishikawa cells, target cells were seeded 
into 6 well plates and allowed to attach. 1 ml fresh medium mixed with 1 ml virus-
containing supernatant was added into each well 18 h after cell plating. Polybrene was 
added into the mixture at a final concentration of 4 ug /ml to enhance the efficiency of 
infection. 48 h later, the virus containing medium was replaced with fresh medium 
supplemented with 0.5 ug/ml puromycin and 1 nM E2 for the antibiotic selection of 
successfully transfected cells. This medium was refreshed every 3 days. Cells that 
survived 7 days’ puromycin selection were then expanded in population. After culture 
with 1 nM E2 for 3 days, GFP positive cells were then sorted out using fluorescence 
activated cell sorting (FACS) Aria cell sorter (BD-Biosciences, Franklin Lakes, NJ). 
The cell line based on MCF7-BOS was designated as MCF7-GFP. The cells derived 
from Ishikawa cells were designated as Ishikawa-GFP. MCF7-GFP and Ishikawa-GFP 
stock cells were maintained in the same way as their parent cell lines, which have been 
described in detail earlier. 
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2.3.5 GFP assay with stably transfected MCF-7 and Ishikawa cells   
MCF7-GFP or Ishikawa-GFP cells were seeded into 24-well plates (Costar, Corning, 
NY) at initial concentrations of 1.6 x105 cells per well (MCF7-GFP) and  8 x 104 cells 
per well (Ishikawa-GFP) respectively. Cells were allowed to attach overnight. Media 
were then replaced with 500 ul per well of fresh media supplemented with 5% CDFBS 
and dosed with chemicals of interest. CDFBS is charcoal/dextran treated FBS with 
reduced steroid levels. Fluorescence intensity of GFP in each well was then quantified 
after 48 h. In the GFP assay, chemicals were tested alone for estrogenicity 
measurements, or tested in the presence of 0.1 nM E2 to assess their antiestrogenic 
activities. Response was reported as a relative fluorescence using the saturated 
response at 1 nM or 0.1 nM E2 as the maximal value. Four measurements based on 
two independent wells dosed at 1 nM or 0.1 nM E2 were made from each set of 
experiments. 
 
To test the effect of steroid starvation on cell response, cells were preconditioned in 
culture medium supplemented with 5% CDFBS instead of FBS for 0, 24 or 48 h 
before being exposed to 0.1 nM E2. GFP responses from cells were then quantified 
after another 48 h. To investigate possible synergistic activities of estrogenic 
compounds combinations, compounds were tested alone at designated concentrations, 
or were mixed 1:1 (v/v) with another chemical of interest at the concentrations of 
interest. 
 
2.3.6 Optical imaging and data analysis  
Cells were observed and imaged under an IMT-2 phase contrast and fluorescence 
microscope (Olympus America Inc., Center Valley, PA) at 100 X. Fluorescence and 
transmission images were captured with a Retiga CCD camera (Qimaging, Burnaby, 
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BC, Canada) in a 12 bit grayscale format, and were analyzed using ImagePro Plus 
software (Media Cybernetics Inc., Silver Spring, MD). The GFP fluorescence intensity 
in cells was calculated as the average optical density per pixel of cells. Means and 
standard errors of the fluorescence intensity were calculated using Origin (OriginLab, 
MA). Graphs were prepared using Origin with results representing the mean ± 
standard error of the mean. Best fit curves were generated using logistic fit of the data. 
The asterisk denotes statistical significance using the Student’s t-test ( p < 0.05 ). 
 
2.4 Results and discussion  
2.4.1 Establishment of an ERE-regulated dual-cell line GFP expression system. 
 In this work we generated stably transfected mammary and endometrial cell lines to 
detect estrogen receptor agonistic and antagonistic compounds, demonstrated their 
capability to identify natural or man-made estrogenic compounds, and studied these 
compounds’ tissue-specific effects and possible synergistic interactions. The parent 
cell lines were carefully selected.  MCF7-BOS is one of the most responsive cell lines 
for E-screen assay [35]. Ishikawa is a well-differentiated human endometrial 
adenocarcinoma cell line [38] that is used as a model for uterine tissue [37, 41]. 
Retrovirus infection of MCF7-BOS or Ishikawa cells with plasmid pQCXIP-2ERE-
GFP and an initial selection with puromycin resulted in mixed cell populations with 
various levels of GFP expression. With fluorescence-activated cell sorting, cells with 
strong GFP fluorescence were separated from cells with very weak or no GFP 
fluorescence after a 48 h’s treatment with E2. Fluorescent cells were collected as 
MCF7-GFP and Ishikawa-GFP. Both cell lines had relatively homogeneous levels of 
GFP expression within each individual cell line.  Frozen cell stocks were prepared. For 
all the experiments, cells were used within ten passages after thawing. 
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Figure 2.2 (A) Dose response curve of the MCF7-GFP cells to E2. Cells were treated 
with 17β-estradiol (E2) for 48 h at concentrations from 10-13 M to 10-7 M at log 
intervals. Cells responses are presented as % of green fluorescence protein (GFP) 
activity induced by 1 nM E2. (B) MCF7-GFP cells treated with 1 nM E2 showed a 
strong expression of GFP. (C) Cells not treated with E2 exhibited only a weak 
fluorescence background. Cells were imaged at 100 X.  
 
2.4.2 Responses of MCF7-GFP and Ishikawa-GFP cells to estradiol  
The sensitivity and responsiveness of transfected cell lines were evaluated with E2. 
Stable transfectants were treated with E2 for 48 h at concentrations from 10-13 M to 10-
7 M at log intervals. GFP fluorescence within cells was measured with a fluorescence 
microscope. As described in Materials and Methods, the observed fluorescence was 
presented as a ratio of measured fluorescence in the well at a given dose to that 
fluorescence measured for a dose of 10-9 M E2. A dose of 10-9 M E2 was saturating 
and maximal. All wells had the same initial cell number. In MCF7-GFP cells, relative 
GFP fluorescence intensity increased in a dose-response manner from a basal level at 
10-12 M E2 to a maximal expression at 10-10 M E2, but didn’t increase further even 
with higher concentrations of E2 (Figure 2.2). Fifty percent effective concentration 
(EC50) value was calculated to be approximately 20 pM based on the dose response 
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curve. Similar responses to E2 were observed in Ishikawa-GFP cells (Figure 2.3) with 
a slightly higher sensitivity and a lower EC50 value of 9 pM. 
 
 
 
Figure 2.3 (A) Dose response curve of the Ishikawa-GFP cells to E2. Cells were 
treated with 17β-estradiol (E2) for 48 h at concentrations from 10-13 M to 10-7 M at log 
intervals. Cells responses are presented as % of green fluorescence protein (GFP) 
activity induced by 1 nM. (B) Ishikawa-GFP cells treated with 1 nM E2 showed a 
strong expression of GFP. (C) Cells not treated with E2 exhibited only a weak 
fluorescence background. Cells were imaged at 100 X.  
 
To verify that the GFP reporter gene activity was ER-mediated, ICI 182780 was co-
administrated with 1nM E2 in both MCF7-GFP and Ishikawa-GFPcultures.ICI 
182,780 is a “pure” antiestrogen that down-regulates ER [42, 43].  A pure antiestrogen 
refers to antiestrogens with high affinity for ER but without any agonist effects. In 
both cell lines, the induction of GFP by E2 was inhibited in dose-dependent manners 
by ICI (Figure 2.4), indicating that the binding of E2 to estrogen receptors is essential 
for expression of the GFP reporter gene.  
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2.4.3 Effect of steroid starvation on assay sensitivity  
Estrogen starvation was performed by preconditioning cells in medium supplemented 
with steroid-deprived CDFBS. In both MCF7-GFP and Ishikawa-GFP cultures, steroid 
starvation caused a stronger GFP response to E2 than non-starved cultures (Figure 
2.5A, 2.5B). In MCF7-GFP cultures with starvation periods of 0, 1 or 2 days, the ratio 
of fluorescence in E2 exposed cultures (0.1 nM E2) to untreated controls was 2.2, 2.2, 
and 1.9, respectively. In contrast the Ishikawa-GFP cultures had a ratio of induced 
fluorescence (0.1 nM E2) to untreated controls starved for 0, 1 and 2 days as 5.7, 6.7 
and 7.2 respectively. The effects of steroid starvation and length of starvation affect 
Ishikawa-GFP cultures more than MCF7-GFP cultures. 
 
 
 
Figure 2.4 Dose responses of MCF7-GFP and Ishikawa-GFP cells to estrogen 
antagonist ICI 182,780 (ICI) in the presence of 1 nM E2. Cells responses are presented 
as % of green fluorescence protein (GFP) activity induced by 1 nM E2.  
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Steroid starvation is used in MCF-7 cell proliferation assays [44] and gene 
transcription assays [25, 26, 30] to identify estrogenic compounds. The duration of 
steroid starvation may last one to three days [25, 30, 44] or even seven days [26]. It is 
suggested that preconditioning in medium with CDFBS up-regulates the expression of 
estrogen receptors in cells, and consequently increases the cells’ sensitivity to 
estrogens [44]. Our results showed that in Ishikawa-GFP cultures, the ratio of 
fluorescence intensity between E2 treated cells and the control cells increased slightly 
(26%) with two days of CDFBS preconditioning.  However, in MCF7-GFP cells, 
despite of the increase of GFP intensity in E2 treated samples, the ratio of fluorescence 
in treated and control cultures changed little.   
 
In the remainder of this study, the steroid starvation step was omitted from the GFP 
assays to shorten the duration of the experiments and to allow us to monitor MCF7-
GFP and Ishikawa-GFP cells simultaneously. Since the ratio of fluorescence in treated 
and non-treated controls was relatively constant, the omission of this step has little 
impact on the experimental response. 
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Figure 2.5 The effects of steroid starvation on cells’ responses to 17β-estradiol (E2) 
were investigated in both (A) MCF7-GFP and (B) Ishikawa-GFP cells. Cells were 
preconditioned in cell culture medium supplemented with charcoal-dextran stripped 
fetal bovine serum (CDFBS) for 0, 1 or 2 days before being exposed to 0.1 nM E2. 
Fluorescence intensity of GFP was measured after 48 h of incubation. The data are 
reported as fluorescence units (FU) per pixel of cells.  
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2.4.4 Responses to natural or synthetic estrogens, environmental EDs, and 
progesterone  
The performance of this assay was evaluated using the natural estrogens E2 , 2-OHE2 
and the synthetic estrogens  DES. Dose-response data are presented as a percent of 
their respective 1 nM E2 control response. DES is a synthetic estrogen used earlier in 
the 20th century to prevent miscarriage. It was banned in 1971 for its teratogenic 
effects and increased cancer risk is associated with DES exposure. In MCF7-GFP cells, 
DES displayed a strong estrogenic activity and induced a sharp GFP intensity increase 
at 10-10 M (Figure 2.6A). The fluorescence intensity obtained with 10-9 M E2 was 
achieved with 10-9 M DES. Similar results were observed in Ishikawa-GFP cells with a 
90% of 10-9 M E2 induction achieved with 10-10 M DES (Figure 2.6B).  These results 
indicated that DES is a strong estrogen with potency comparable to E2.  2-OHE2 is a 
major metabolite of E2. 2-OHE2 also induced a dose-dependent increase of GFP 
intensity with EC50 values of 6.3x10-8 M in MCF7-GFP cells (Figure 2.6A) and 3.2 x 
10-8 M in Ishikawa-GFP cells (Figure 2.6B). The maximal fluorescence intensity 
obtained with 10-9 M E2 was achieved with 10-7 M to 10-6 M 2-OHE2. Thus, 2-OHE2 
appears to be approximately 3,500 times less potent than E2.   
 
Response of this assay to several known estrogenic endocrine disruptors was also 
examined (Figure 2.6A, Figure 2.6B). BPA is a plastic monomer and plasticizer that is 
used in the production of many plastic consumer products and papers, and is one of 
the highest volume chemicals produced worldwide [45]. An increase in GFP intensity 
was observed with 10-6 M BPA in both MCF7-GFP and Ishikawa-GFP cells. Genistein, 
an isoflavone from plants, stimulated the GFP expression at 10-6 M in MCF-7 cells, 
and at 10-7 M in Ishikawa cells.  These results demonstrate that those cell lines respond 
to various chemicals in the expected differential manner. 
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Figure 2.6 Responses of (A) MCF7-GFP and (B) Ishikawa-GFP cells to 
diethylstilbestrol (DES), 2OH-E2, genistein (GEN), bisphenol A (BPA) and 
progesterone (Pro). Data are presented as the % of the GFP activity induced by 1 nM 
17β-estradiol (E2).  
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This dual-cell line assay appears to be specific to estrogens. Non-estrogenic hormones, 
such as progesterone, did not induce GFP expression above the vehicle control in 
either MCF7-GFP (Figure 2.6A) or Ishikawa-GFP cells (Figure 2.6B) at 
concentrations from 10-8 M to 10-6 M. 
 
2.4.5 Comparison of the responsiveness of MCF-7 GFP with Ishikawa-GFP  
In this study, both MCF-7 and Ishikawa cells were transfected with identical 2ERE-
E4-GFP reporter gene constructs through the same retrovirus infection method. This 
was done to minimize variations in cell responses caused by different gene expression 
systems. Estrogenic chemicals tested here (E2, DES, Gen, BPA, 2OH-E2 etc.) 
generated similar response patterns in both MCF7-GFP and Ishikawa-GFP cells. 
However, Ishikawa-GFP cells were more sensitive than MCF7-GFP cells with smaller 
EC50 values. It was also observed that MCF7-BOS cells aggregated when exposed to 
estrogens, which may partially contribute to the increase of GFP intensity. Such an 
effect was not observed in Ishikawa cells. These results may represent intrinsic 
differences between the cells, for example, their distinct gene profiles and different ER 
expression levels [45].   The retrovirus infection process may introduce variances as 
well, possibly with various copies of vector fragments being integrated into the 
genome at different sites.  
 
2.4.6 Tissue-specific effects of tamoxifen and raloxifene  
To assess the anti-estrogenic activities of ICI, tamoxifen and raloxifene, MCF7-GFP 
and Ishikawa-GFP cells were treated with these compounds with or without co-
administration of 1 nM E2. In MCF7-GFP cells, none of the compounds alone 
generated estrogenic activities in the range of 10-10 M to 10-5 M (data not shown). All 
three compounds inhibited E2-induced GFP activity in dose response manners as 
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expected (Figure 2.7A). The GFP fluorescence induction by E2 was completely 
blocked by all three antiestrogens at concentrations above 10-7 M.  However, the 
results in Ishikawa-GFP cells are different. Only ICI, but not tamoxifen and raloxifene, 
was effective in inhibiting E2-induced GFP expression (Figure 2.7B). ICI alone 
stimulated no GFP activity. Tamoxifen and raloxifene, on the contrary, acted as 
estrogen agonists and generated significant estrogenic responses in Ishikawa-GFP 
cells. Tamoxifen produced a significant GFP intensity increase at concentrations 
higher than 10-10 M. The maximal expression was approximately 36% of the level 
induced by 10-9 M E2. Similar results were observed with raloxifene at 10-10 M to 10-5 
M (Figure 2.7B), with a higher maximal GFP induction being about 60% of the level 
induced by 10-9 M E2.  
 
The role of estrogen receptors in these responses was investigated by examining cell 
response to tamoxifen or raloxifene in the presence of ICI. It was observed that ICI 
repressed the estrogenic activities of both tamoxifen and raloxifene at 1 uM in dose 
response manners (Figure 2.8). 
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Figure 2.7  GFP responses to estrogen antagonists ICI 182,780 (ICI), tamoxifen (Tam) 
and raloxifene (Ral) in (A) MCF7-GFP and (B) Ishikawa-GFP cells. Antiestrogens 
were tested with or without co-administration of 1 nM E2. The data are reported as 
fluorescence units (FU) per pixel of cells.  
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Figure 2.8  The effects of ICI on the GFP activities induced by 1uM raloxifene (Ral) 
or tamoxifen (Tam) in Ishikawa-GFP cells. 0.1 uM and 1u M ICI was added onto cells 
treated with Ral or Tam. The GFP fluorescence in cells was measured after 48 h of 
incubation. Data are presented as the % of the GFP activity induced by 1 nM 17β-
estradiol (E2). 
 
The increased risk of endometrial cancer in postmenopausal women under breast 
cancer therapy has been a concern [37, 46]. The challenge is to discover new SERMs 
that display ER antagonist activity on estrogen-dependent mammary tumors, but not in 
endometrial tissue. This dual cell-line system described here can be used as a 
preliminary screening tool for this purpose. Results from this system showed that ICI 
was a strong antiestrogen in both breast cancer MCF7-GFP and endometrial Ishikawa-
GFP cells (Figure 2.7B). Tamoxifen and raloxifene were antiestrogens in MCF-7 cells 
but acted as ER agonists in Ishikawa cells, and exhibited partial estrogenic activities. 
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This conclusion on tamoxifen is consistent with many other studies [47, 48], but the 
results with raloxifene differ from some studies and many of these former studies are 
inconsistent with each other. Raloxifene, a compound for osteoporosis treatment, is 
being tested for breast cancer therapy. It is usually believed that, unlike tamoxifen, 
raloxifene does not increase the risk of endometrial cancer [37, 46]. Liu and coworkers 
[49] reported that raloxifene completely inhibited the activity of 1 nM E2 in a ERE-
Luc reporter assay. In another work, raloxifene, unlike tamoxifen, did not stimulate the 
recruitment of co-activators to a subset of estrogen-response genes [37]. Studies with 
results consistent with ours are also available. Both tamoxifen and raloxifene, but not 
ICI, stimulated the activity of estrogen-sensitive alkaline phosphatase activity in 
Ishikawa cells [41].  Raloxifene was also found to stimulate the growth of Ishikawa 
tumor growth in ovariectomized nude mice [50]. The inconsistency between these 
studies is caused perhaps by the intrinsic variance of the cells or cell lines, and the 
reporter gene systems used in each individual study. 
 
ICI inhibited the estrogenic actions of both tamoxifen and raloxifene in almost 
identical dose response manners (Figure 2.8), indicating that the GFP induction by 
both chemicals were most likely ER mediated. Raloxifene induced a higher GFP 
expression than tamoxifen in Ishikawa-GFP cells, implying that raloxifene is a 
stronger ER agonist than tamoxifen. Together, our data suggested that both tamoxifen 
and raloxifene have stimulatory effects on ER-ERE mediated gene transcriptions in 
Ishikawa cells. 
 
2.4.7 Synergistic interactions between weak estrogenic chemicals 
Possible synergistic activities between weak estrogenic EDs were investigated by 
comparing cells’ responses to a single compound with cells’ responses to chemical 
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mixtures. We first tested E2 in combination with its metabolite, E1, for possible 
synergism. The two chemicals were mixed 1:1 (v/v) at designated concentrations, and 
GFP responses were measured from both MCF7-GFP and Ishikawa-GFP cells. Results 
were illustrated in Figure 2.9A and Figure 2.9B. The combined effect of E2 and E1 
was close to the sum of their individual effects. Interactions between E2 and E1 were 
additive or slightly less than additive (Figure 2.9A, Figure 2.9B). No synergistic 
interaction was observed in either cell lines. Organochlorine pesticides, MXC, o-p'-
DDT and p-p'-DDT were also tested as endocrine disruptors and for synergistic 
interactions. MXC is general pesticide used on food crops, ornamentals, livestock, and 
pets. DDT, a commercial pesticide banned in the 1970’s, is a mixture of p-p'-DDT and 
its inactive isomer o-p'-DDT. Figure 2.10A and Figure 2.10B illustrated responses of 
MCF7-GFP and Ishikawa-GFP cells to 1 uM MXC, o-p'-DDT, p-p'-DDT or their 
equimolar binary mixtures. Of these compounds only o-p'-DDT induced a statistically 
significant response over the control in MCF7-GFP cultures, but both  o-p'-DDT and 
MXC induced significant responses in Ishikawa-GFP cultures.The combinations 
between these three compounds showed additive GFP activity in MCF7-GFP cells. In 
Ishikawa-GFP cells, interactions between o-p'-DDT and MXC, or between o-p'-DDT 
and p-p'-DDT were slightly less than additive. 
  
Since numerous estrogenic agents have been identified in the environment, concerns 
are being raised about whether synergism occurs in humans exposed to multiple 
environmental estrogen mimics.  Synergistic effect is not uncommon in drug 
toxicology and may be due to various mechanisms, including receptor interaction and 
changes in effector mechanisms [51, 52]. However, there have been conflicting reports 
regarding the existence of synergism between steroidal estrogens and environmental 
endocrine disruptors.  Synergistic effect was observed between E2, E1 and 17α-
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Figure 2.9  Transcription activation of GFP in (A) MCF7-GFP cells or in (B) 
Ishikawa-GFP cells by 0.001 nM E2, 0.1 nM E1, 0.01 nM E1 and their 1:1 (v:v) 
mixtures, 0.001 nM E2 and 0.1 nM E1 (0.001 nM E2/0.1 nM E1), 0.001 nM E2 and 
0.01 nM E1 (0.001 nM E2/0.01 nM E1) . Fluorescence intensity of GFP in cells 
treated with 0.1 nM E2 (0.1 nM E2) and in the cells receiving solvent only (ctrl) are 
shown for comparison. The data are reported as fluorescence units (FU) per pixel of 
cells. Asterisks denote statistical significance of the response of the individual 
chemical as compared to the perspective vehicle control. * p < 0.05. 
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Figure 2.10  Transcription activation of GFP in (A) MCF7-GFP cells and (B) 
Ishikawa-GFP cells by 1 uM methoxychlor (mxc), o-p'-DDT (op), p-p'-DDT (pp) and 
their equimolar binary mixtures of p-p'-DDT and o-p'-DDT (op/pp), o-p'-DDT and 
MXC (op/mxc), p-p'-DDT and MXC (pp/mxc). Fluorescence intensity of GFP in cells 
treated with 1 nM E2 (1 nM E2) and in the cells receiving solvent only (ctrl) are 
shown for comparison. The data are reported as fluorescence units (FU) per pixel of 
cells. Asterisks denote statistical significance of the response of the individual 
chemical as compared to the perspective vehicle control. * p < 0.05. 
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 estradiol [53], and with environmental chemicals such as dieldrin, endosulfan and 
toxaphene [5, 54]. It was also observed with endocrine-disrupting chemicals that 
interact with nuclear receptors other than ERs [54, 55]. But many other studies 
reported only additive effects between dieldrin and toxaphene [56], and 
organochlorine pesticides [57]. In this study we repeated some of these experiments 
with the same or similar compounds and concentrations with our dual-cell line GFP 
expression system. No evidence of synergistic activity was detected between MXC, o-
p'-DDT, p-p'-DDT, nor between E2 and E1. However, since we only studied limited 
combinations of chemicals at specified concentrations, possible synergistic effect 
cannot be excluded. We suggest that estrogenic interactions of weakly estrogenic 
chemicals may be highly dependent on assays, including choices of cell lines, 
chemicals and doses. 
 
2.5 Concluding remarks  
Unlike most reported transcription assays that study chemical responses only in one 
cell line, this dual cell line system allows simultaneous investigations in both 
mammary and endometrial cells with a same gene transcription system. This is of 
great importance in the study of estrogens, antiestrogens or SERMs that can act in a 
tissue-specific manner. The two most notable observations in this study was the 
differential response (tissue specific) to tamoxifen and raloxifene and the lack of 
synergistic interactions of estrogenic chemicals.  
 
The use of GFP in this dual-cell line system offer many advantages. Quantification of 
other reporters such as Luc and CAT require cell lysis and enzyme substrate, which 
make it difficult to perform on modern microfluidic cell culture devices, especially on 
microCCA with multi types of cell cultures. GFP is a photostable fluorophore for 
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analytical measurements, requires no cofactors or substrates for fluorescence to occur, 
and can be easily monitored in situ without cell disruption [58]. These stable cells with 
GFP as a reporter enable label-free and direct quantification of cell responses on 
compact microfluidic biosensors, such as microCCA chip devices. The simplicity of 
such an assay facilitates high throughput screening, whether in a traditional static or 
well-based assay or in a flow based microfluidic system. 
 
The EC50 value of E2 following a 48 h exposure was approximately 9 pM in 
Ishikawa-GFP cells, similar to that observed in other GFP assays [9, 30], but are 
slightly larger than the EC50s measured in some Luc-based assays (6 pM, Legler et al., 
1999; 3 pM, Wilson et al., 2004). As an enzymatic assay, Luc activity detection was 
usually more sensitive and rapid than protein expression, such as GFP [58, 59].  While 
steroid starvation may increase potentially the sensitivity of transcription assay, it was 
omitted in our measurements as we observed only modest increase in response even 
after two day starvation. Another factor that influences the sensitivity of an assay is the 
number of copies of ERE in the plasmid, where more copies of ERE are likely to 
increase the sensitivity of the reporter assay. 3 x ERE were used in the two Luc 
reporter assays mentioned above, while we used 2 x ERE in our dual-cell line system. 
A lower number of copies of ERE, however, reduces ligand-independent activities 
[60].  
 
We believe that this GFP-based transcription assay will contribute to improved 
screening of estrogen, antiestrogen and SERMs compounds.  It is a simple and stable 
aid in clarifying toxicological mechanism of chemical actions, and to address tissue- 
specific effects in mammary and endometrial tissues. In our laboratory this dual-cell
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line assay is currently used with microCCA devices to identify estrogenic and 
antiestrogenic compounds. Liver cells cultured on the same chip devices enable the 
identification of pro-estrogens or pro-antiestrogens, which are activated by liver 
metabolism, and are most likely to be overlooked in a traditional static cell culture 
system.  We also developed and are currently characterizing cell lines transfected with 
an AP1-E4-GFP construct. Future research with all these cell lines and the microCCA 
would facilitate identification of ER agonists and antagonists that act through both 
ER-ERE and ER-AP1 pathways. Such a system should lead to a clearer picture of 
crosstalk between these pathways. Dual cell lines should be an important tool in the 
study of how estrogen receptor modulators behave in a tissue-specific manner.  
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CHAPTER 3* 
 
QUANTIFICATION OF CHEMICAL - POLYMER SURFACE INTERACTIONS IN 
MICROFLUIDIC CELL CULTURE DEVICES 
 
3.1 Abstract 
Microfluidic cell culture devices have been used for drug development, chemical 
analysis and environmental pollutant detection. Due to the decreased fluid volume and 
increased surface area to volume ratio, interactions between device surfaces and the 
fluid is a key element that affects the performance and detection accuracy of 
microfluidic devices, particularly if fluid is recirculated by a peristaltic pump. 
However, this issue has not been studied in detail in a microfluidic cell culture 
environment. In this study, chemical loss and contaminant leakage from various 
polymer surfaces in a microfluidic setup were characterized. The effects of 
hydrophilic coating with Poly (vinyl alcohol), Pluronic® F-68 and multi-layer ionic 
coating were measured. We observed significant surface adsorption of estradiol, 
doxorubicin, and verapamil with PharMed® BPT tubing, while PTFE/BPT and 
stainless steel/BPT hybrid tubing caused less chemical loss in proportion to the 
fraction of BPT tubing in the hybrid system. Contaminants leaching out of the BPT 
tubing were found to be estrogen receptor agonists as determined by estrogen induced 
green fluorescence expression in an estrogen responsive Ishikawa cell line. These 
contaminants also caused interference with an estradiol ELISA assay. Stainless  
Steel/BPT hybrid tubing caused the least interference with ELISA. In summary, 
polymer surface and chemical interactions inside microfluidic systems should not be 
 
 
1 This chapter is based on “Quantification of Chemical - Polymer Surface Interactions In Microfluidic 
Cell Culture Devices” by Hui Xu and Michael L. Shuler, Biotechnol Prog, 25(2):543-51, 2009 
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neglected and require careful investigations when results from a microfluidic system 
are compared with results from a macro scale cell culture setup. 
 
3.2 Introduction 
The development of microfluidic cell culture devices has been rapid in the areas of 
bioprocessing, drug development, toxicology assessment and clinical diagnosis[1, 2]. 
Minimization of device size lowers device cost, decreases chemical usage and waste 
production, and potentially accelerates interactions between chemicals and cells or 
sensors due to decreased diffusion distances. In addition, introduction of flow into cell 
culture devices allows dynamic and precise control over cellular and subcellular micro 
environment, provides physiology-related shear forces, and enables continuous 
feeding of cells [3-5].  
 
Materials used for microfluidic cell culture devices may be glass, silicon, ceramics, 
metal, plastics or polymer hydrogels [5-10]. However, disposable plastic materials are 
most popular because of their low cost and disposable nature, which significantly 
reduces preparation and cleanup time, avoids cross-contamination, and makes devices 
lightweight and portable. Examples of such materials include polystyrene, 
polyethylene, polycarbonate, silicon, Polydimethylsiloxane (PDMS) and Poly(methyl 
methacrylate) (PMMA, Plexiglas®) [11].  
 
Flow systems typically use peristaltic or diaphragm pumps. Peristaltic pumps are 
especially useful since the moving parts are not in contact with the fluid. However, the 
operation of a peristaltic pump usually requires flow through soft plastic tubing. 
Popular tubing materials used in pharmaceutical and biotechnology applications with a 
peristaltic pump include silicone, polyvinyl chloride (PVC), and polypropylene-based 
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PharMed® BPT. The latter one is widely used with cell culture due to its durability, 
good chemical resistance and excellent biocompatibility. 
 
Interactions between polymers and chemicals have been extensively investigated in 
macro-scale devices for bioprocessing and pharmaceutical manufactures. Non-specific 
surface adsorption caused chemical loss have been characterized. For example, 
adsorption of protein onto PDMS, PMMA [12, 13] are significant. And loss of linoleic 
acid or cholesterol onto polyethylene cell culture medium storage bag [14] and 
polypropylene cell culture devices have been found to affect cell growth negatively 
[15]. A second concern regarding polymer-fluid interactions is the leakage of 
plasticizer and additives from polymers. Bisphenol A (BPA) leaks from used 
polycarbonate into water to levels of 310 ug per L [16]. And di-(2-ethylhexyl phthalate) 
(DEHP) migration from PVC films used extensively in food packaging has raised 
health concerns [17]. These interactions are influenced by temperature, type of 
solution, pH, etc. Deposition of hydrophilic polymers such as poly (ethylene glycol) 
(PEG) and poly (vinyl alcohol) (PVA) onto polymer surfaces is the most common 
method to both minimize non-specific adsorption and to decrease migration of 
contaminant from polymers [12, 17, 18]. 
 
Despite extensive previous work on characterizing chemical-polymer interactions at 
macro-scale, few studies have quantified such interactions in a dynamic microfluidic 
cell culture environment. One of the key characteristics of microfluidic devices is the 
high surface area to volume ratio.  Many microfluidic cell culture devices try to 
reproduce in vivo like cellular micro environment where the physiological value of 
liquid to cell volume ratio is about 0.5; this ratio in traditional cell culture flasks and 
dishes is from 200 to 300.  As a result, interactions between fluid and device surface 
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are amplified in a microfluidic system. Chemical loss due to surface adsorption and 
migration into polymer matrix should increase in high surface area to volume systems. 
In addition, potential leaching of chemicals from tubing is also of great concern than 
in traditional large-scale bioreactors. For example, significant loss of hydrophobic 
compounds such as Nile Red and dodecyl sulfate was significant due to either 
absorption[19] or adsorption[20] within PDMS microfluidic structures. 
 
Our group has developed microscale cell culture analog (microCCA), also called 
“Body-on-a-Chip” devices, to evaluate the efficacy and toxicity of potential 
pharmaceuticals and environmental chemicals [4, 5, 21]. A microCCA device is a 
simplified and minimized model of the human body, using mammalian cell cultures to 
represent key functions of specific organs. Multiple human cell lines, such as the 
human mammary, endometrial and liver cells, are cultured in respective organ 
chambers. These chambers are designed to embody the structure of a Physiologically 
Based Pharmacokinetic (PBPK) model [22] using living cells in a bioreactor 
compartment instead of differential equations. Cell culture medium (total volume of 
200 ul) is recirculated inside a closed-loop system consisting of a microCCA silicon 
chip sandwiched between two Plexiglas® housing pieces, a small medium reservoir, 
and a 55 cm long BPT tube that connects the reservoir and the chip together. About 20 
cm of tubing is embedded in a peristaltic pump to drive flow. Cells have been 
successfully cultured on the device for up to 96 h with good cell viability. In proof-of-
concept studies, a microCCA was used to test potential mechanisms of toxicity of 
naphthalene on lung cells [4, 5]. A hypothetical mechanism where lung toxicity was 
due to conversion of naphthalene in the liver to naphthoquinone and the circulation of 
naphthoquinone from the liver to other tissue compartments was found to be plausible. 
Further, it was demonstrated that fat provided partial protection of lung cells from 
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death and glutathione depletion when challenged with naphthalene or naphthoquinone 
[23]. Current applications include selection of drug resistance modulators [24], drug 
screening for cancer therapy, and toxicity assessments of environmental hormones. It 
is in this latter application that chemical leaching and adsorption are especially 
problematic.  
 
Most hormones are very potent and the concentrations required for the body to 
respond are very low (nM to uM) compared to many other chemicals (uM to mM). In 
addition, most hormones, such as estrogens, are hydrophobic compounds. 
Consequently, the non-specific interactions between hydrophobic compounds with 
hydrophobic polymer surfaces cannot be overlooked. Furthermore, contaminates 
leaked from polymers will accumulate in a closed-loop recirculation system, and are 
more likely to influence or alter experimental outcomes.  
 
In this study chemical adsorption and contaminant leakage from polymer surfaces 
were characterized using HPLC, enzyme-linked immunosorbent assay (ELISA) and a 
green fluorescence protein (GFP) based cell line assay. Our results show that 17β-
Estradiol (E2), doxorubicin hydrochloride (Dox), and verapamil (VRP) in cell culture 
media experienced significant loss after long-term contact with plastic BPT tubing. 
Hydrophilic surface coatings didn’t eliminate this problem. Stainless steel (SS) and 
PTFE hybrid tubes were able to alleviate adsorption. In addition, contaminates 
released from BPT tubing caused estrogen stimulated cellular responses in human 
endometrial cells. Interference was also detected in PTFE tubing with or without 
hydrophilic coatings. Stainless steel hybrid tubing caused the least interference in 
estradiol ELISA. When microfluidic systems are used for toxicity assessments and for 
detection of low concentration of chemicals, careful investigation of surface 
B 
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adsorption and contamination release must be conducted.  
 
3.3 Materials and methods 
3.3.1 Chemicals and reagents  
E2, Dox, daunorubicin, VRP, benzo-f-quinoline, polybrene, dextran sulfate, PVA and 
Pluronic® F-68 (PF) were purchased from Sigma (St. Louis, MO).  Defined fetal 
bovine serum (FBS) and charcoal/dextran treated fetal bovine serum (CDFBS) with 
reduced steroid levels were from Hyclone (Logan, UT). E2 ELISA Kit was from 
Cayman Chemical (Ann Arbor, MI). 
 
Microbore PharMed® BPT tubing (ID = 0.25 mm) and polytetrafluoroethylene (PTFE) 
tubing were purchased from Cole-Parmer (Vernon Hills, IL). Stainless steel 
hypodermic tubing (24G, ID = 0.30 mm) was from Small Parts, Inc (Miami Lakes, 
FL). The peristaltic pump used in this study was a multi-channel Watson-Marlow 205S 
pump (Watson-Marlow and Bredel, Baldwinsville, NY). Polystyrene stripwells used 
as medium reservoirs were purchased from Corning Incorporation (Corning, NY). 
Molded PTFE/Silicone Liners were from Biotech Solutions (Vineland, NJ).  
 
3.3.2 Ishikawa-GFP cell line maintenance and GFP assay  
The development of stable Ishikawa-GFP cell line for quantification of estrogenic 
compounds has been previously described[25]. In short, a two tandem estrogen 
response elements (2ERE) – adenoviral E4 promoter – GFP reporter gene construct 
pQCXIP-2ERE-GFP was introduced into Ishikawa cells through retrovirus infection. 
Successfully transfected cells were selected out with antibiotic selection and 
fluorescence activated cell sorting (FACS).The stable transfectant Ishikawa-GFP cell 
line exhibited increased GFP expression when exposed to estrogens. Ishikawa-GFP 
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cells were cultured in minimum essential medium (MEM) (Invitrogen, Carlsbad, CA) 
supplied with 10% FBS and maintained at 37°C in a humidified, 5% CO2, 95% 
atmosphere incubator. 
 
For GFP assay, Ishikawa-GFP cells were seeded into 96-well plates (Costar, Corning, 
NY) at initial concentrations of 1.4 x 104 cells per well. Cells were allowed to attach 
overnight. Frozen medium samples from experiments were thawed. Then 0.2 mM L-
glutamine was added to medium samples to compensate for glutamine decomposition 
during 3 day incubation at 37°C. In addition, medium samples from the experiments 
assessing the loss of E2 in tubing were diluted 10,000 to avoid the saturation of GFP 
signals with 0.1 nM or higher concentrations of E2. Prepared medium samples of 100 
ul were then added into each well of cell culture after equilibration to 37°C. GFP 
fluorescence intensities were quantified after 48 h. Cells were observed and imaged 
under an IMT-2 phase contrast and fluorescence microscope (Olympus America Inc., 
Center Valley, PA) at 100 X. Fluorescence images were captured with a Retiga CCD 
camera (Qimaging, Burnaby, BC, Canada) in a 12 bit grayscale format. 
 
3.3.3 Quantification of association of compounds to tubing surfaces  
Rather than using a full microCCA system, a simpler system was used for 
recirculation through a reservoir (Figure 3.1A). Experiments were performed with a 
Watson-Marlow 205S multi-channel peristaltic pump. Chemicals of interested, 1 uM 
E2, Dox or VRP, were added into cell culture medium supplied with 10% CDFBS. 200 
ul medium per well were then aliquoted into strips wells used as medium reservoirs. 
The wells were sealed with molded PTFE/silicone liners. Tubing used in this study 
were 55 cm long BPT tubing, BPT/PTFE hybrid (with 20 cm long BPT tubing and 35 
cm long PTFE tubing or BPT/SS hybrid tubing (with 20 cm long BPT tubing and 35 
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cm long SS tubing) (Figure 3.1B). The 20 cm long soft BPT tubing was necessary to 
work with the peristaltic pump. The ends of each BPT or BPT hybrid tubing were 
inserted into the reservoir, and cell culture medium was then recirculated inside the 
tubing and the reservoir at 3 ul per min for 72 h. All tubes were sterilized by 
autoclaving for 30 min, rinsed with water for 30 min, and then rinsed again with 
appropriate medium before the experiments. All experiments were performed inside a 
humidified, 5% CO2, 95% atmosphere cell culture incubator at 37°C. When the 
experiments were done, medium reservoirs were frozen at -20°C until further analysis 
with HPLC or ELISA.  
 
 
Figure 3.1 Schematic representation of experimental setup (Figure 3.1A), and the 
stainless steel (SS)/BPT hybrid tubing (Figure 3.1B) as an example of the hybrid 
tubing used in this study. The lengths of SS tubing and BPT tubing are 35 cm and 20 
cm. The ends of the tubes were inserted into a medium reservoir with 200 ul cell 
culture medium. Flow rate was set at 3 ul per min. 
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Two types of controls samples were prepared for each set of experiments. Frozen 
control samples were 500 ul unused medium samples maintained at -20℃ in 
polypropylene vials. Reservoir only control samples were 200 ul medium samples in 
the polystyrene reservoirs that were incubated along with the experimental medium 
samples in the cell culture incubator, but without medium recirculation.  
 
3.3.4 Hydrophilic surface coating  
1% (w/v) PVA, 3% (w/v) PF or multi-ionic (MI) layer coating were used to coat the 
inner surface of various tubing materials. For PVA and PF coating, tubes were first 
rinsed with sterile Milli-Q water for 30 min at 20 ul per min. 1% PVA or 3% PF was 
then pumped through the tubes for 10 min and allowed to sit for 25 min. Fluid was 
then pumped out of the tubes, and air was pumped through the tubing for 30 min. MI 
coating was adapted from a method described by Johns and Hayes [26]. Tubes were 
first treated with 0.1 M sodium hydroxide for 4 min, followed with a 4 min rinsing 
with sterile Milli-Q water. A 5% (w/v) polybrene solution was pumped through the 
tubes continuously for 2 min and allowed to stand for 15 min before being pumped out. 
3% dextran sulfate was then pumped through the tubes for 2 min and allowed to stand 
for 15 min.  Tubing was then rinsed with sterile Milli-Q water for 10 min, followed 
with appropriate medium rinse for 30 min. 
 
Tubes were sterilized with a dry autoclave run of 30 min before surface coatings. All 
the coating processes were performed within a cell culture hood to maintain sterility.  
 
3.3.5 Chemical loss in medium droplets placed on top of plastic pieces 
Polycarbonate and Plexiglas® were cut into 2 cm x 2 cm square pieces and wipe-
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cleaned with 70% ethanol. Plastic pieces were treated with oxygen plasma in an 
Expanded Plasma Cleaner (Harrick Plasma, Ithaca, NY) for 2 min followed by PF or 
PVA coatings. 200 ul cell culture media with or without 1 uM E2 were aliquoted onto 
the plastic pieces and incubated for 24 h in a humidified, 5% CO2, 95% atmosphere 
cell culture incubator at 37°C. Medium droplets were aspirated carefully into 1 ml 
polypropylene tubes (VWR.com, West Chester, PA) and were frozen for further 
analysis with ELISA. 
 
3.3.6 Quantification of Dox and VRP with reverse-phase HPLC  
Dox and VRP were extracted from medium samples with a cold methanol 
precipitation method described previously in literature [24, 27]. In short, 140 ul ice 
cold methanol was mixed with 50 ul cell culture medium samples and 10 ul internal 
standard: 1.6 uM daunorubicin for Dox or 0.33 uM benzo-f-quinoline for VRP. The 
mixture was mixed well and centrifuged at 4℃ for 10 min at 9000 x g. The 
supernatants were then transferred into polypropylene screw top HPLC vials (Waters 
Corp., Milford, MA) for analysis.  
 
Dox and VRP were quantified with a Waters 2690 separation module and a Waters 474 
fluorescence detector (Waters Corp., Milford, MA) following the method described in 
the literature [24, 27, 28]. The column used for Dox was a 150 mm x 4.6 mm Xterra 
RP C18 column (Waters Corp.; Milford, MA). Fluorescence detection was realized at 
excitation wavelength of 480 nm and emission wavelength of 560 nm. The mobile 
phase consisted of 65% 50 mM mono sodium phosphate, 25% acetonitrile and 2% 1-
isopropanol, with a flow rate of 1 ml per min.  Column used for VRP is a 150 mm x 
3.9 mm Novapak column (Waters Corp., Milford, MA). VRP was detected at 276 /310 
nm (Ex./Em.) with a mobile phase consisting of 35% acetonitrile and 0.03% 
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triethylamine, pH = 3.8. Flow rate was set at 0.9 ml per min. 
 
3.3.7 Quantification of E2 and interference factors with ELISA  
E2 in medium samples were quantified with an Estradiol ELISA kit (Cayman 
Chemical, Ann Arbor, Michigan) as instructed. The measurement is based on the 
competition between estradiol and an estradiol-acetylcholinesterase conjugate for 
limited amount of estradiol antiserum. The concentration of estradiol-
acetylcholinesterase conjugate is held constant, while the amount of estrogen in the 
samples varies. The antiserum-estradiol complex binds to the IgG mouse monoclonal 
antibody that was previously attached to the well. After washing, color is developed 
with Ellman's reagent, and optical absorbance is measured at 412 nm with a 
VERSAmax microplate reader (Molecular Devices, Sunnyvale, CA).  
 
Medium samples were diluted when necessary in order to be in the detection range of 
the ELISA test. 300 times dilutions were conducted for medium samples from the 
experiments for quantifying the loss of E2 in various tubing, where 1 uM E2 was 
added into the medium at the starting point of the tests.  
 
3.3.8 Ethanol extraction of E2 from tubing surface 
Immediately following the experiments quantifying loss of E2 within plastic tubing, 
tubes were rinsed with 10 ml Milli-Q water to remove loosely adhered chemicals. 
Each tubing was then connected to a HPLC polypropylene vial (Waters Corp., Milford, 
MA) filled with 200 ul absolute ethanol, which was recirculated through the tubing 
overnight at 20 ul per min to extract E2 off the tubing surface.  
 
The extracts were evaporated to dryness in a SpeedVac concentrator (Thermo Savant, 
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Holbrook, NY), and the remaining residues were re-dissolved completely into 200 ul 1 
M phosphate buffer (Cayman Chemical, Ann Arbor, MI). Samples were frozen at -
20°C until further analysis. E2 concentrations in the buffer were quantified with 
ELISA. 
 
3.3.9 Statistical analysis  
Four measurements based on two independent tubing were made for each individual 
experiment condition. Means and standard errors of the measurements were calculated 
using Origin (OriginLab, MA). Data are presented in the figures as the mean ± 
standard error of the mean.  
 
3.4 Results and discussions 
3.4.1 Loss of E2, Dox and VRP in microbore BPT tubing  
Because of the hydrophobic nature of most plastics, they tend to adsorb small 
hydrophobic molecules such as lipids, proteins, vitamins and hormones onto their 
surfaces [14, 15]. However, limited studies have been conducted regarding chemical 
loss in microfluidic devices, inside which such polymer-chemical interactions are 
expected to be more prominent than in macro-scale fluidic devices due to increased 
surface area to volume ratio. In this study, losses of three hydrophobic compounds, E2, 
Dox and VRP in microbore tubes were characterized. These chemicals were selected 
because they were currently of interest to our lab and were being extensively used in 
our research projects. MicroCCA was designed based on human physiological 
parameters, and was a physical representation of a human body. Flow rate of the 
medium recirculation was calculated based on fluid residence time in individual 
organs [4, 5, 7]. The external reservoir represents ‘other tissue’ that were not present 
on the chip. Volume of the reservoir (200 ul) was selected to maintain the same trends 
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and order of magnitude of chemicals distribution in the tissues of interest. A larger 
volume of medium would increase volume/surface ratio and make the culture less 
physiologically realistic. In microCCA, the medium is recirculated constantly through 
the reservoir, tubing and cell culture chambers, which mimics the blood circulation 
pattern in the body. Such a system can address issues of reactive metabolite formation 
and tissue-tissue interaction through exchange of metabolites or signal molecules [4, 
7]. Other experimental parameters such as the period of experiments were based on 
experimental protocols for use of a microCCA. Typical operation time for microCCA 
is 72 h. This period of 72 h is consistent with prior studies where, for example, 72 h 
was sufficient for the association of cholesterol and linoleic acid with polytheylene to 
reach steady-state [14].  
 
Figure 3.2 shows the decreased chemical concentration in the cell culture medium due 
to recirculation in the BPT tubing. Chemical concentrations were quantified with 
HPLC. Data are plotted as percent of chemical concentration in the control samples 
that were kept frozen at -20℃ (frozen controls). All three chemicals, E2, Dox and VRP 
suffered significant loss due to adsorption to surfaces. For 1 uM E2 and VRP, 
incubation in polystyrene reservoirs at 37℃ for 72 h caused less than 9% chemical 
loss. However, recirculation within BPT tubing caused an additional 80% loss of E2. It 
also caused an additional 91% loss of VRP, leaving the amount of VRP remaining in 
the cell culture medium lower than the limit of detection with HPLC. For 1 uM Dox, 
half of the chemical was lost after 72 h at 37℃ in the reservoir, likely due to 
degradation of Dox because of light sensitive and unstable nature of this compound, as 
well as surface adsorption to the reservoir. Recirculation through the BPT tubing 
caused another 32% loss, leaving only 0.18 uM Dox in the cell culture medium after 
72 h.  
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Figure 3.2 Chemical losses in medium after 72 h recirculation within BPT tubing. 
Data were plotted as the percent of [E2] in control samples that that were frozen and 
not recirculated through the tubing. The initial concentration of chemicals added into 
the medium was 1 uM. Verapamil values were undetectable after recirculation through 
the BPT tubing. A value of 100% corresponds to the measured level in control samples 
that were frozen and not recirculated through the tubing. 
 
Loss of E2 was also demonstrated with Ishikawa-GFP cell based transcription assay. 
Ishikawa-GFP is a human endometrial carcinoma cell line with stable estrogen 
stimulated GFP expression [25]. Natural estrogenic compounds such as E2, and 
environmental estrogens such as o,p-DDT and BPA bind to estrogen receptors and 
interact with ERE to initiate GFP expression. Ishikawa-GFP exhibited increased GFP 
expression to estrogens in a dose-response manner with an EC50 value of 9 pM E2. 
GFP responses saturated with E2 concentrations higher than 0.1 nM [25]. Such 
responses are specific to estrogens. Before the GFP assay, 0.2 mM L-glutamine was 
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added into all medium samples, which were maintained at 37°C for 3 days in the 
experiments characterizing E2 loss. Since L-glutamine is more labile in solution than 
other amino acids and its breakdown is accelerated at 37°C, replenishment is 
important to prevent glutamine from limiting cellular response [29]. The medium 
samples were never freeze-thawed more than once if the medium was to be used for 
cell culture. 
 
 
Figure 3.3 Responses of Ishikawa-GFP cell to medium samples supplied with 1 uM 
estradiol and (A) recirculated within BPT tubing for 72 h, or (B) kept in the reservoirs 
without contact with the BPT tubing. Medium samples recirculated within BPT tubing 
induced less GFP expression in Ishikawa-GFP cells, indicating that less estradiol was 
available to the cells.  Cells were imaged at X 100 . 
 
Figure 3.3 presents response of Ishikawa-GFP cells to E2 in medium samples initially 
spiked with 1 uM E2 before the 3 day recirculation test. Medium samples were diluted 
10,000 times to avoid the saturation of GFP responses. It was observed that after 
recirculation in BPT tubing, medium samples induced significantly less GFP 
expression (Figure 3.3A) than controls (Figure 3.3B). These results indicate that less 
E2 was available in the medium after 72 h’s recirculation within BPT tubing compared 
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to samples that were kept in the reservoirs without contact with BPT tubes. This result 
is consistent with the measurements from HPLC. 
 
Figure 3.4 Effects on the loss of estradiol (E2) in BPT tubing and BPT/PTFE hybrid 
tubing with: N/O, no coating; PVA, Poly (vinyl alcohol) coating; PF, Pluronic® F-68 
coating; MI, multi-ionic layer coating with polybrene and dextran sulfate. The 
reservoir control (Reservoir) corresponds to samples that were in the reservoir for 72 h 
without recirculation in the tubing. A value of 100% corresponds to the measured level 
in control samples that were frozen and not recirculated through the tubing.  
 
3.4.2 Effects of hydrophilic coating on chemical adsorption  
Most disposable labware and medical implements are fabricated from plastics. 
However their hydrophobic nature can cause issues with non-specific adsorption and 
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poor fluid wettability. Hydrophilic polymers such as PVA[30], AerosolTM, GeroponTM 
and PluronicTM surfactants [30] have been used for surface functionalization of fluidic 
devices at both macro and micros scales. Multi-ionic (MI) layer, or polyelectrolyte 
multilayer coating is another popular surface modification method for microchip 
analytical devices [26]. PVA, Pluronic® F-68 (PF) and MI coating were easy to 
perform and require no harsh chemicals. 
 
Figure 3.4 showed the effect of PVA, PF and MI hydrophilic coatings on the surface 
adsorption of E2 in BPT or BPT/PTFE hybrid tubing. The concentrations of E2 
detected in the medium were plotted as the percent of amount of E2 in the samples 
frozen and never placed in the reservoir or re-circulated. With BPT tubing, PF coating 
decreased the adsorption of E2 significantly and increased the amount of E2 remaining 
in the reservoir. The effects of PVA or MI coatings, however, were negligible. Without 
hydrophilic coatings, PTFE/BPT hybrid tubing caused less E2 loss than BPT tubes, 
leaving three times’ higher concentration of E2 in the medium after 72 h recirculation. 
Coating with PVA, PF and MI, surprisingly, increased surface adsorption of E2, while 
the effect by PF coating was more prominent. The losses of E2 with different 
hydrophilic coatings depend on the substrate (i.e. BPT or PTFE), which indicates the 
stabilities of hydrophilic coatings on BPT or PTFE might not enough during 
recirculation. The reason of using PTFE/BPT hybrid rather than PTFE tubing alone is 
that PTFE tubing is rigid while flexible BPT tubing was needed for insertion into the 
Watson-Marlow 205S peristaltic pump head.  However, even at the best situation of 
PTFE/BPT tubing, only approximately 38% of 1 uM E2 was available in the medium. 
The loss of about 50% E2 caused by recirculation within plastic tubing, may greatly 
affect how cells respond to E2 and other hydrophobic compounds. Alternatives to 
peristaltic pumps that can maintain recirculation at 3 ul per min for extended periods 
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of times, which allow use of only PTFE tubing, would reduce adsorption. 
 
It was unclear whether E2 losses were due to adsorption onto the tubing surface and 
migration of E2 into the plastic. To test this hypothesis, E2 on the tubing surface or 
near-surface was extracted with an overnight ethanol rinse, which was conducted after 
the tubes were used to recirculate 1 uM E2 medium for 72 h. The concentration of E2 
detected in the extraction solution was plotted on the right side of Figure 3.5 (Figure 
3.5R), and the quantity of E2 in the medium from Figure 3.4 was re-plotted in Figure 
3.5 (Figure 3.5L) for comparison. All data are presented as the percent of E2 
concentration in the frozen samples (initially spiked with 1 uM E2). It was observed 
that, when less E2 was detected left in the medium, a higher concentration of E2 was 
usually detected in the extraction solutions. And the total amount of E2, TE2 = 
[E2]medium + [E2]extraction, was relatively constant despite the different coating 
conditions or tubes used. TE2 equaled about 50% of the amount of E2 initially added 
into the cell culture medium. The only exception was for BPT tubing without 
hydrophilic coating, where the total amount of E2 was measured lower than the other 
situations. BPT tubing is polypropylene based material with mineral oil and other 
blend materials. One possible explanation for this observation is that, when BPT 
tubing was not coated with hydrophilic polymers, mineral oil within the BPT matrix 
may have increased E2 migration into the tubing matrix; E2 diffused into the bulk 
polymer would not be extracted efficiently with ethanol. TE2 was different from total 
amount of E2 in the control sample (92%), possibly because of the incomplete 
extraction from the tubing surface, and again the inefficiency of ethanol rinsing to 
extract chemicals from the bulk polymer. 
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Figure 3.5 Extraction of estradiol (E2) from tubing surface (R). Data were plotted 
together with the amount of E2 measured in the medium (L) after recirculation within 
BPT or BPT/PTFE hybrid tubes coated with Poly (vinyl alcohol) (PVA), Pluronic® 
F68 (PF) or no coating (N/O). A value of 100% corresponds to the measured level of 
E2 in control samples that were frozen and not recirculated through the tubing. 
 
3.4.3 Chemical leaching from polymer tubing  
Manufacture of plastic tubes usually involves the use of solvents, plasticizers, 
antioxidants and other additives. These additives blended into the tubing material may 
leach out during autoclaving or normal use. As tubes used in microfluidic devices have 
small inner diameters (e.g. 0.19 mm), with the increased surface to fluid volume ratio 
in microbore tubing and microfluidic devices, contaminating chemicals leaching into 
the fluid may accumulate and cause unwanted interference. The kinetics of chemical 
leakage can be influenced by pH, temperature, type of solution, surfactants [31] and a 
variety of environmental parameters. Coating with hydrophilic polymers has been 
shown to decrease the release of contaminates such as plasticizers [17].   
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Figure 3.6 Interference with the E2 ELISA assay caused by medium recirculation for 
72 h within BPT and PTFE/BPT hybrid tubing with different surface coatings. The 
interference values were presented as activities relative to the activity of 1nM E2. The 
reservoir control (Reservoir) corresponds to samples that were in the reservoir without 
recirculation in the tubing. N/O, no coating; PVA, Poly (vinyl alcohol); PF, Pluronic® 
F-68; MI, multi-ionic layer coating with polybrene and dextran sulfate. 
 
We used estradiol ELISA to quantify the interference in medium introduced by 
recirculation inside tubes. As no E2 was added into the medium samples, an activity 
detected from the ELISA indicates the presence of certain compounds in the samples 
that interfere with the immunoassay. Although ELISA does not provide direct 
information for chemical identification, it allows the comparison of the relative 
amount of interference introduced by different materials and coating conditions. These 
interferences could be caused by chemicals with structures similar to E2, such as 
genistein, or any chemicals that alter ligand-antibody binding, including solvent. In 
this study, ethanol and dimethyl sulfoxide (DMSO) were used to dissolve chemicals; 
and mineral oil is a component in the BPT tubing.  Under our experimental conditions, 
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ethanol, DMSO or mineral oil in the medium did not cause significant interference 
(with p > 0.1 using the Student’s t-test) with the ELISA test with concentrations of 0.1% 
(v/v) or less (data not shown).  
 
Recirculation of medium within BPT or PTFE/BPT hybrid tubing caused significant 
interference (Figure 3.6) compared to the condition without recirculation in tubes 
(reservoir only controls). The interference values were presented as activities relative 
to the activity of 1nM E2. Hydrophilic coatings with PVA, PF or MI didn’t decrease 
contamination release, but instead caused a higher amount of interference. The 
antioxidant additive in polymer powder or solutions, such as butylated hydroxytoluene 
(BHT) in PF powder, which has been found to be weakly estrogenic in a human 
embryonic kidney fibroblast cell line based assays [32], may be the cause of increased 
interference in our ELISA measurements. Figure 3.7 presents the different responses 
of Ishikawa-GFP cells to medium samples (with no addition of E2) without 
recirculation (Figure 3.7A) or after being recirculated within tubes (Figure 3.7B). The 
samples that stayed only within the reservoirs didn’t induce GFP expression. However, 
medium after a 72 h’s recirculation within BPT tubing caused a significant GFP 
induction in Ishikawa-GFP cells. The expression of GFP was blocked with ICI 
182,780 (Figure 3.7C), which increases degradation and down-regulates estrogen 
receptors [33]. These results indicates that contaminates were released from BPT 
tubing, and at least some of these contaminates were able to interact with estrogen 
receptors and elicit estrogen-like responses in Ishikawa-GFP cells.  
 
The activity of such interference was in the order of 0.1% of the activity of 1uM E2. It 
was significant when compared to control samples when no E2 was added into the 
samples. However, it was insignificant and negligible when compared to the amount 
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of E2 (in the range of 0.1 to 1uM) in samples from the experiments quantifying the 
loss of E2 in tubing, thus had no effect on those experimental outcomes. 
 
 
Figure 3.7 Responses of Ishikawa-GFP cells to cell culture medium samples (without 
addition of estradiol) kept (A) in the reservoir, or (B) recirculated within BPT tubing at 
3 ul per min for 72 h. Contaminant leaked from the BPT tubing induced GFP 
expression in Ishikawa cells (B), which was blocked by 1 uM ICI182,780 (C).  Cells 
were imaged at X 100. 
 
The specific contaminates responsible for such interference have not been fully 
identified.  We excluded the possibility of cross-contamination between tubes as tubes 
were all individually labeled and those used with E2 and those for experiments 
without E2 were separated. Based on literature reports, we speculate that these 
contaminates could be one or a mixture of plasticizers or other additives used to 
produce polypropylene or polypropylene-based BPT tubing. Various plasticizers used 
in plastic production, such as tris(2-ethylhexyl)trimellitate (TEHTM), di-isoheptyl 
phthalate (DIHP) [34] and bisphenol-A [16, 35, 36] have been found to be weak 
estrogens and induced estrogenic responses in reporter-gene based transcription assays 
[34, 37].  
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Figure 3.8 Comparison of (A) loss of Estradiol (E2) and (B) release of interference in 
BPT and stainless steel (SS)/ BPT hybrid tubing. With 1 uM E2 initially added into the 
medium, three-time higher concentration of estradiol was detected in medium within 
SS/BPT hybrid tubing compared to that in BPT tubing. The interference from stainless 
steel hybrid tubing was half of that amount from BPT tubing.  
 
3.4.4 Loss of E2 and release of interference in stainless steel hybrid tubing  
Stainless steel tubing is corrosion-resistant, exceptionally tough, relatively flexible, 
and is ideal for many applications in bioprocessing and analysis such as high pressure 
liquid chromatography. With stainless steel/BPT hybrid tubing, the adsorption loss of 
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E2 was decreased, but not eliminated. Three time higher concentration of E2 remained 
in the medium compared to BPT tubing alone (Figure 3.8A). Chemicals released from 
stainless steel tubing were also less problematic and caused about 60% less 
interference in the ELISA assay (Figure 3.8B) than chemicals released from the BPT 
or PTFE/BPT hybrid tubing. 
 
3.4.5 Loss of E2 and release of interference into medium on top of plastic pieces 
In addition to microbore tubing, most microfluidic devices use polymers such as 
Plexiglas®, PDMS, polycarbonate and other plastics as body or housing materials. In 
microCCA devices developed in our lab, the silicon microCCA chip is sandwiched 
between two Plexiglas® or polycarbonate pieces [4, 5, 7]. Medium recirculating inside 
the channels and cell culture chambers is in direct contact with the Plexiglas® or 
polycarbonate housing, which may cause chemical loss or contaminations as well as 
with the tubing. Such effects were quantified by measuring chemical loss and 
contamination release by placing a drop of medium (200 ul) onto clean plastic pieces. 
These experiments were performed for a period of 24 h instead of 72 h to minimize 
medium evaporation and contamination issues.  
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Figure 3.9 (A) Loss of estradiE2) and (B) release of interference from polycarbonate 
and Plexiglas® pieces. 200 ul media were placed onto square plastic pieces and 
incubated for 24 h. Plastics were treated with oxygen plasma (Plasma) and coated with 
Poly (vinyl alcohol) (PVA) or Pluronic® F-68 (PF) or with no surface treatment (N/O) 
right before the placement of medium drops. Plasma treatment and PVA coating 
caused more E2 loss compared to the other two conditions. Interference to ELISA 
caused by all conditions were observed but were minor compared to that from BPT 
tubing. The interference values were presented as activities relative to the activity of 
1nM E2. 
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Significant losses of E2 were observed on both polycarbonate and Plexiglas® pieces 
with or without hydrophilic coatings (Figure 3.9A). Although plastic surfaces are 
usually oxidized and more hydrophilic after oxygen plasma treatment, in this study 
plasma treatment alone or followed by PVA coating slightly increased the loss of E2 
and decreased its amount in the medium compared to no surface treatment (Figure 
3.9A). Similar results were observed with PF coating followed by a plasma treatment. 
Incubations on polycarbonate or Plexiglas® pieces did caused a increase of 
interference to the ELISA assay, but the interference was much smaller compared to 
that caused by recirculation in polymer tubing (Figure 3.9B). Since these studies were 
carried on at static state rather than at a dynamic situation with constant flow, and the 
incubation time was relatively short, larger chemical loss and contaminant release are 
expected under microCCA experimental conditions. Plexiglas® and polycarbonate 
pieces used in this study were both new materials and no obvious difference between 
new Plexiglas® and polycarbonate was observed here. However, it has been reported 
that BPA was released from used polycarbonate plastic into waters [16]. 
 
3.5 Conclusions 
In the present work, chemical losses and contaminant leakage inside a microfluidic 
cell culture device setup were characterized in both microbore polymer tubing and on 
selected plastic surfaces. Significant chemical loss (up to about 100%) was observed 
with E2, DOX and VRP with BPT tubing. The effect of hydrophilic coating on surface 
adsorption was material-dependent. PTFE/BPT and stainless steel/BPT hybrid tubing 
were more resistant to surface adsorption than BPT tubing alone. Chemicals leached 
from BPT tubing caused estrogenic responses in human endometrial cells, and 
interfered with E2 ELISA assays. Stainless steel was able to decrease this interference. 
Since the embedded segment of BPT tubing inside the pump is constantly squeezed 
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and stretched during peristaltic pumping, both chemical release and chemical 
adsorption are expected to be higher than BPT tubing outside the pump. Less chemical 
adsorption and contaminant release are expected if 100% PTFE or stainless steel 
materials are used, which may require the replacement of current peristaltic pump with 
other micropumps to eliminate the need for soft tubing. Glass or ceramic capillaries 
are also possible choices for similar applications but they have not been tested in our 
system due to their fragility.  
 
As a result, chemical loss and contaminant release may alter experimental outcomes, 
and need be considered when results from microfluidic devices are compared to 
conventional cultures especially when low concentrations of hydrophobic compounds 
are studied. For example, chemical loss may affect dose responses and the 
measurement of EC50 with cells cultured in microfluidic devices. Interference caused 
by chemical leaching in a microfluidic system should also be carefully examined and 
eliminated when possible.  
 
We believe that this study should be of general interest especially to researchers 
working with hydrophobic compounds and microfluidic devices. It is expected that 
these studies may serve as a guideline for their future studies.  
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CHAPTER 4 
 
DEVELOPMENT OF A SILICON CELL CULTURE ANALOG DEVICE TO 
STUDY ENDOCRINE DISRUPTORS 
 
4.1 Abstract  
The general population is exposed to a variety of environmental chemicals that might 
inadvertently disrupt the endocrine system of humans and wildlife. However, in vitro 
assays for rapid screening and in depth understanding of such compounds are limited. 
In this work, physiologically realistic microCCA devices were developed to help 
predict in vivo responses to EDs.   The silicon microCCA device contained a co-
culture of three cell lines: MCF7-GFP (breast origin), Ishikawa-GFP (uterine origin) 
and HepG2/C3A (liver origin). Recirculation of medium mimicked the time dependent 
changes in the concentration of a chemical compound and its metabolites. Introduction 
of the flow also reproduced the microfluidic shear conditions inside a body.  In 
addition, an in-line bubble tip was developed for bubble removal from the microfluidic 
pathways and to overcome air bubble related device failure that occurred in previous 
designs.  It was found that the BPT tubing previously used with the peristaltic pump 
for microCCA leached ED like chemicals. A PDMS pneumatic micropump with a 
pumping rate ~3 ul per min was build to replace the bulky peristaltic pump. The 
micropump was used together with microCCA devices to detect estrogens. 
Preliminary results also showed tissue specific responses from uterine and breast 
derived cell lines. 
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4.2 Introduction 
Estrogens are essential hormones in regulating the development and functions of the 
reproduction, nervous, skeletal and the cardiovascular systems. Over the last decade, 
there has been growing concern that estrogenic pollutants in the environment, such as 
dichlorodiphenyltrichloroethane (DDT) [1] and bisphenol A (BPA), may mimic 
natural hormone estrogens, interfere with the normal endocrine system, and elicit 
adverse health issues in both humans and wildlife [2].  Exposure to estrogenic 
endocrine disruptor (ED) chemicals in humans may adversely influence female 
fecundity and fertility, cause developmental and reproductive diseases, and increases 
the incidence of estrogen-related cancers [3-5]. These concerns have been heightened 
by the possibility that mixtures of weak EDs may exhibit complex synergistic 
interactions [6].             
 
A variety of in vivo and in silico models have been developed for screening of 
potential ED compounds and their mixtures. In vivo animal assays, such as  
environmental assays [7], rodent uterotrophic assays [8] and the multigenerational 
tests [9],   are costly and time consuming. It is also difficult to extrapolate human 
responses accurately from animal models. Computational tools, such as the nuclear 
receptor quantitative structure–activity relationship (QSAR) [10] and molecular 
docking [11, 12] have constrained predictability due to the limited structural similarity 
of estrogenic EDs.  Recently DNA microarrays have been used to recognize the 
pattern of gene transcription in target cells stimulated by estrogens, which is then used 
to identify potential estrogenic compounds [13-15]. While a significant advance 
technology, microarray technology requires careful sample preparation and 
hybridization, as well as complex data analysis. More importantly, microarray analysis 
may not be able to address response to mixtures and provides limited opportunities to 
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probe subcellular mechanisms. Hormone receptor binding assays measure the affinity 
of a compound to ER, but provide no specific information about its agonist or 
antagonist effects.  
 
Current in vitro tools for the study of EDs also have their limitations. The cell 
proliferation test (E-Screen) [16]  identifies estrogenic chemicals by their proliferative 
effects,  yet it suffers from lack of specificity, lengthy test times (5 to 6 days) and 
inability to produce direct insights into the molecular basis of chemical toxicity. 
Methods employing reporter gene expression systems for estrogenicity measurements 
are typically fast and sensitive [17]. We reported earlier the development of two stably 
transfected GFP reporter cell lines, MCF7-GFP and Ishikawa-GFP, to detect 
estrogenic and antiestrogenic compounds [18]. This dual cell line system enables 
simultaneous in vitro study of the toxicity effect of ED in both mammary and 
endometrial tissues. However, cell culture in the in vitro systems described above is 
usually static, while in vivo the physiological environment cells experience is dynamic 
due to exchange of compounds between organs and tissues, as well as the mechanical 
forces generated by recirculation.  Also, only one individual cell type is studied at a 
time in these standard assays (using microwell plates, etc.). The physical and chemical 
interconnections between different organs are overlooked. As a result, most in vitro 
systems are incapable of providing useful information about the pharmacokinetics 
inside a human body, and usually fail to make connections between the toxicity effect 
and the pharmacokinetic profile of a toxin or a drug. 
 
In this work a novel in vitro system, termed as microscale cell culture analog 
(microCCA), was developed to evaluate the toxicity of environmental endocrine 
disruptors. The device is 2.5 cm x 2.5 cm in size on a silicon wafer. Multiple human 
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cell lines, including the mammary, endometrial and liver cells were cultured on the 
device in separate yet interconnected organ chambers. Cell culture medium (200 ul) is 
re-circulated through them as a blood surrogate. The physical microCCA system is a 
direct analog to a Physiologically Based Pharmacokinetic (PBPK) modeling [19]. 
Since reaction rates in flow limited models are determined by residence time, size of 
the chambers is calculated to provide a liquid residence time similar to that in the 
tissue or organ. The relative size of compartments is set by the ratio of organ sizes. 
MicroCCA provides a more physiology-relevant dynamic environment for 
assessments of chemical toxicity in multiple cell lines simultaneously. It was also 
capable of addressing the issues of response to pro-estrogens with a “liver” 
compartment to mimic formation of active estrogenic compounds and tissue-tissue 
interaction through exchange of metabolites. In addition, a home-made bubble tip was 
described as an in-line debubbler for microCCA. It is a better alternative to 
commercial debubblers for many microfluidic devices as it has a smaller inner volume 
and requires no additional tubing connections. 
 
The microCCA was tested with selective estrogen receptor modulators ICI 182,780 
and tamoxifen. ICI suppressed GFP expression induced by E2 in both Ishikawa-GFP 
and MCF7-GFP cells while the effect of tamoxifen was tissue specific. Results from 
microCCA experiments also suggested the presence of ED chemicals leaching out 
from polypropylene based tubing (BPT) used with the bulky peristaltic pump. To 
overcome this problem, a compact micropump is described here for precise control of 
on-chip perfusion. Incorporation of the compact micropump with microCCA increases 
its capability for parallel testing at large numbers of samples.  
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In summary, this work describes an in vitro system that may be able to better predict 
human response to environmental estrogens and other toxins.  
 
4.3 Materials and methods 
4.3.1 Chemicals and reagents  
E2, ICI 182,780 (Fulvestrant, ICI), 4-hydroxy tamoxifen (Tam) and raloxifene 
hydrochloride (Ral) were purchased from Sigma (St. Louis, MO).  Fetal bovine serum 
(FBS) and charcoal-dextran stripped fetal bovine serum (CDFBS) with reduced steroid 
levels were from Hyclone (Logan, UT). Human plasma fibronectin was acquired from 
Millipore (Billerica, MA). Multi-well plates were purchased from Corning Life 
Science (Corning, NY). Single side polished silicon wafers ((100), 500-550 um in 
thickness, 100 mm in diameter) were obtained from Wafer Works Corporation (San 
Jose, CA). P20 and Shipley 1813 and 1027 photoresist were purchased from Shipley 
Company (Marlborough, MA). MIF 300 developer was obtained from Claricut 
(Somerville, NY). 
 
4.3.2 Cell culture  
The construction of stable MCF7-GFP and Ishikawa-GFP cell lines for quantification 
of estrogenic compounds has been previously described [18]. In short, a two tandem 
estrogen response elements (2ERE) – adenoviral E4 promoter – GFP reporter gene 
construct, pQCXIP-2ERE-GFP, was introduced into Ishikawa cells through retrovirus 
infection. Successfully transfected cells were selected out with antibiotic selection and 
fluorescence activated cell sorting (FACS). The stable transfectant MCF7-GFP and 
Ishikawa-GFP cell lines exhibited increased GFP expression when exposed to 
estrogens.  
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The parental MCF7-BOS cells were kindly provided by Dr. Ana Soto and Dr. Carlos 
Sonnenschein (Tufts University School of Medicine, Boston, MA). These cells, as 
well as MCF7-GFP cells, were maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM) (MP Biomedicals, Solon, OH) supplemented with 5% heat inactivated FBS. 
Heat inactivated FBS was prepared by heating FBS in a 57℃ water bath for 30 
minutes followed by a filtration through a 0.2-micron filter. The parental Ishikawa 
cells were a kind gift from Dr. Myles Brown (Dana-Farber Cancer Institute, Boston, 
MA). Ishikawa and Ishikawa-GFP Cells have been maintained in Minimum Essential 
Medium (MEM) (Invitrogen, Carlsbad, CA) with 10% FBS.  HepG2/C3A cells were 
obtained from the American Type Culture Collection (Manassas, VA), and were 
maintained in MEM with 1.0 mM sodium pyruvate and 10% FBS. All the cells were 
cultured at 37°C in a humidified, 5% CO2, 95% atmosphere incubator. 
 
4.3.3   MicroCCA design and fabrication 
4.3.3.1 MicroCCA design 
MicroCCA chips were designed based on a simplified PBPK model of the human 
body (Table 4.1). The body is divided into liver, mammary gland, uterus, fat and the 
other tissues. Parameters, such as blood flow rate, residence time, etc are obtained 
from the literature. Physical parameters of each chambers and channels are carefully 
adjusted and calculated to balance the pressure drop between medium inlet/outlet, to 
maintain the residence time consistent with in vivo situations.  
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Table 4.1 Physiological parameters for the PBPK model [20-23] 
 
 Liver Mammary Uterine Fat 
Blood fraction (%) 24 1.35 0.62 5.0 
Blood Flow rate  (mL/s) 23.2 1.31 0.60 4.83 
Tissue volume (L) 1.50 0.21 0.09 15.1 
Residence time (s) 65 161 158 3124 
 
4.3.3.2 MicroCCA fabrication 
The microCCA chips were fabricated at the Cornell Nanofabrication Facility (CNF) 
using standard photolithography and etching techniques that have been described 
previously [24]. Briefly, the pattern was first designed with L-Edit Layout Editor 
(Tanner EDA, Monrovia, CA). The pattern was then directly written onto a 127 mm (5 
inch) chrome-coated glass mask via Heidelberg DWL 66 laser writer (Heidelberg 
Instruments, Germany).  A 4 inch diameter, 525 um thick silicon wafer was primed 
with P20 primer at 300 rpm for 30 sec to promote adhesion for photoresist. Next, the 
wafer was coated with 1.2 um of Shipley 1813 photoresist at 3000 rpm. A 1 min pre-
exposure bake, or soft bake, on a 90°C vacuum hot plate was used to drive the solvent 
from the resist. The mask pattern was transferred onto the wafer with a 40 sec UV 
exposure (405 nm) on a Hybrid Technology Group's (HTG) system III-HR 
contact/proximity mask aligner (San Jose, CA). Resist was developed in a Hamatech-
Steag Wafer processor with 300MIF developer for 1 min. Chambers on the chip were 
etched into the chip via a single chamber (licensed Bosch fluorine process) inductively 
coupled plasma / reactive ion etcher Unaxis 770 (Unaxia USA Inc., St. Petersburg, 
FL). Resist hot strip bath was used for stripping photoresist off the wafers with heated 
AZ 300T (Clariant Corporation, Somerville, NJ). The wafer was then rinsed clean 
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with DI water and dried. 1 inch x 1 inch individual chips (6 per wafer) were separated 
with a K&S 7100 Dicing Saw (Kulicke & Soffa Industries Inc., Fort Washington PA) 
After each use, cells were killed and detached from the device by immersing the 
microCCA chips into Clorox overnight. The piranha solution consisting of 3:1 ratio of 
30% hydrogen peroxide (H2O2) and sulfuric acid (H2SO4) was used to clean and 
hydroxylate the silicone substrate surface of the microCCA chip. 
 
4.3.3.3 Fabrication of the housing  
Housing was fabricated from plexiglass (McMaster-Carr, New Brunswick, NJ) by 
Glenn Swann (school of Chemical and Biomolecular Engineering). The size of the top 
was 4.13 cm x 4.13 cm with a thickness of 0.3 cm. The bottom piece was 4.13 cm x 
4.13 cm with a thickness of 0.46 cm. Inlet and outlet holes (D = 0.14 cm) were drilled 
into the top piece. The beginning part of the holes were enlarged a little (D = 0.17 cm) 
to facilitate the insertion of plastic tips connected to medium tubing. A 2.55 cm x 2.55 
cm chamber with a depth of 0.5 mm was machined into the bottom piece to house the 
microCCA chip. The size of this chamber was precisely controlled to ensure a good 
alignment of the inlet/outlet holes with the inlet/outlet on the chip device, yet also 
allow easy placement of the chip into the chamber. Thread was drilled on the bottom 
piece for clamping the two piece housing together with screws. 
 
For each set of housing pieces, two stainless steel pins were added onto the bottom 
piece, and holes were drilled out on the top piece at corresponding positions. These 
pins would guide the top piece toward the right position relative to the bottom piece 
during device assembly.  
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4.3.3.4 Construction of a bubble tip as an air bubble trap  
Bubble tips were made from polypropylene gel loading tips. Two gel loading tips were 
cut for each bubble tip (Figure 4.1); (A) was cut at about 8 mm above the flexible 
capillary tip, and (B) was cut at about 5 mm above the flexible capillary tip. (B) was 
then inserted into the opening of (A) to achieve a tight fit. For better sealing, 
polydimethylsiloxane (PDMS) prepolymers were mixed at a 10 1 w/w-mixture of 
monomer and hardener (Sylgard 184, Dow Corning). The mixture was degassed under 
vacuum for 10 min, and then was used to seal the connection. The assembled bubble 
tips were baked at 60°C oven overnight to cure the PDMS adhesive. This PDMS 
sealing process may be omitted as the binding strength between part (A) and part (B) 
are usually sufficient under low pressure situation with microCCA. To use the bubble 
tip as a bubble trap, the shorter end of bubble tip was connected to the tubing that 
comes out the peristaltic pump. The longer end was inserted into the inlet hole on the 
top housing piece of the microCCA device.  
 
 
Figure 4.1 Construction of the bubble tip as a debubbler. 
 
 
 
4.3.4 Cell culture on the microCCA device 
HepG2/C3A, Ishikawa-GFP and MCF7-GFP cells were grown in T25 cell culture 
flasks until they reached 80% confluence. Cells were then detached and re-suspended 
104 
 
in cell culture medium. The microCCA chip was first coated with 8 ug/cm2 human 
plasma fibronectin (Chemicon International Inc., Temecula, CA) in DPBS for 30 min 
at room temperature. Upon removal of the fibronectin solution, MCF7-GFP cells were 
seeded into the mammary chamber at a concentration of 250,000 cells per cm2, 
Ishikawa-GFP cells were seeded into the uterine chamber at a concentration of 
500,000 cells per cm2, and HepG2/C3A cells were seeded into the liver chamber at a 
concentration of 300,000 cells per cm2. The chips were kept in the cell culture 
incubator overnight to allow the cells to attach and spread. To reduce evaporation of 
the medium and avoid drying of the cell suspension, several drops of cell culture 
medium were placed on the bottom of the culture dish holding the chips. In 
experiments testing surface treatment different conditions,  the bottom of wells in a 
24-well plates were treated with collagen, 4 ug/cm2 poly-D-lysine in DPBS, 8 ug/cm2 
fibronectin, or fibronectin alone for 30 min before cell suspension being added to the 
wells. After 24 h cell attachment, 0.5 ml cell culture media with 10-9 M E2 or no E2 
were added into each well. Cell responses were recorded after 48 h. 
 
4.3.5 MicroCCA assembly 
Before assembly of the microCCA device, tubing and reservoir coverings were first 
sterilized with dry autoclaving for 30 min. The commercial peristaltic pump was 
wiped with 70% alcohol and placed into the cell culture laminar hood. Tubing 
connected with the bubble tip was placed into the cassette of the peristaltic pump. The 
longer end of the bubble tips should point upward for easy removal of the air inside 
the body of the bubble tips when medium was introduced. The tubing was briefly 
rinsed with DPBS at 50 rpm, and then rinsed with cell culture medium at 5 rpm for 30 
min. Flow rate was further slowed down to 0.75 rpm before assembling chips. 
Housing pieces for microCCA were wiped with 70% alcohol and allowed to air dry. 
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The top housing pieces were then cleaned in an oxygen plasma cleaner (Harrick 
Plasma, Ithaca, NY) for 2 min to increase wettability. Plasma treatment also improved 
sterilization. Then 0.5 ml cell culture media were immediately pipetted onto the 
plasma treated surface of each top housing piece to help maintain the hydrophilic 
nature of the plastic pieces. 
 
 
Figure 4.2 Assembly of the microCCA devices.  
 
To sandwich a microCCA chip between the Plexiglas housing pieces, the microCCA 
chips were first placed into the bottom housing piece (Figure 4.2). A PDMS gasket 
was used under the chips as a cushioning material for better sealing. Then 300 ul cell 
culture medium was added onto the chip to cover all the chambers and channels. The 
longer end of the bubble tip was then inserted into the inlet hole in the top housing 
piece. The inner side of the top housing piece to be in contact with the microCCA chip 
was then rinsed with 1 ml media to remove any air bubbles.  The top housing piece 
was then pushed straightly down onto the bottom housing piece with the guidance of 
the guiding pins and screws were tightened. The outlet tubing was then inserted into 
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the outlet hole in the top housing piece. Finally the medium reservoir with 200 ul cell 
culture medium was connected with the tubing to form a closed recirculation system.  
 
4.3.6 Fabrication of the PDMS micro pump 
The PDMS micro pump has two main components, the membrane and the pump body. 
To make the PDMS membrane, silicon wafers were coated with (1H, 1H, 2H, 2H-
Perfluorooctyl)Trichlorosilane (FOTS) (oxygen plasma 60 s, reaction 600 s), which is 
an excellent antistiction coating and is usually used as a release layer, on a Molecular 
Vapor Deposition tool (MVD100, Applied Microstructures Inc., San Jose, CA). 
PDMS was mixed at ten parts of polymer precursor and one part of cross-linking agent 
by weight. A 50 um PDMS membrane was generated by spin coating of PDMS 
mixture on a piece of silicon wafer at 1400 rpm for 45 s. The membrane was then 
cured on a 100 °C hot plate for 4 min and in a 60 °C oven for 1.5 h. Thickness of the 
PDMS membranes was measured with a Tencor P10 profilometer (KLA-Tencor, San 
Jose, CA). 
 
The body of the micropump was fabricated using a soft lithography method (Figure 
1.2). First, SU8 2050 negative photoresist (MicroChem, Newton, MA) was spun onto 
a silicon wafer to form a layer with a thickness of 50 um. Then it was soft-baked at 65 
◦C for10 min and then at 95 ◦C for 20 min. A standard photolithography process was 
performed for pattern transfer, followed by a post-exposure-bake process at 65 ◦C for 
3 min and at 95 ◦C for 10 min. Finally, the SU8 wafer was development in SU8 
developer for 2 min, rinsed with isopropanol, water and then blow dried with nitrogen.  
PDMS is then cast against this SU8 mold, PDMS was mixed at ten parts of polymer 
precursor and one part of cross-linking agent by weight, and then poured onto the SU-
8 microstructure master. A vacuum process was required to remove the air bubbles 
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formed during the mixing. The PDMS was then cured at 60°C in an oven overnight. 
The PDMS inverse structures were then peeled off the master. The PDMS membrane, 
top and bottom pieces were all sealed together after oxygen plasma treatment for 40 s, 
and the final device was baked on  a 120°C  hot plate for 1 h. Water was filled into the 
medium channels to help maintain the hydrophilic property of the PDMS channels 
from the oxygen plasma treatment. 
 
The device assembly with the micropump was similar to the assembly process with a 
peristaltic pump. However, the process is easier and more straightforward as the 
length of the tubing is much shorter with the micropump. The medium rinsing time 
was also decreased to 10 min.  
 
4.3.7 Detection of estrogenic and antiestrogenic chemicals with microCCA  
HepG2/C3A, MCF7-GFP and Ishikawa-GFP cells were seeded onto the microCCA 
chip as described in the section 4.3.4. Cells were allowed to attach and spread 
overnight. Test chemicals E2, Ral or ICI were dissolved in ethanol and added into 
McCoy’s 5A medium with 10% CDFBS to reach a final concentration of 10-9 M, 10-6 
M and 10-6 M respectively. Only ethanol was added in a vehicle control sample. 
Medium with the test chemical or the vehicle only was used to rinse the individual 
BPT tubing to remove contaminants and to passivate the tubing surfaces with the test 
chemicals.  Then 200 ul medium was filled into each medium reservoir and allowed to 
equilibrate at 37°C in a cell culture incubator. The devices were then assembled and 
operated at 37°C and 5% CO2 for 48 h. At the end of the experiments, the microCCA 
devices were carefully disconnected from the tubing and bubble tip for cell imaging. 
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4.3.8 Imaging method 
Cells were observed and imaged under an IMT-2 phase contrast and fluorescence 
microscope (Olympus America Inc., Center Valley, PA) at 100 X. Fluorescence and 
transmission images were captured with a Retiga CCD camera (Qimaging, Burnaby, 
BC, Canada) in a 12 bit grayscale format, and were analyzed using ImagePro Plus 
software (Media Cybernetics Inc., Silver Spring, MD).  
 
4.4 Results and discussions 
4.4.1 Construction of the microCCA device 
 
 
Figure 4.3  Photograph of the six chamber microCCA device.  
 
The first version of microCCA contained six cell culture chambers for the liver, 
mammary, uterus and fat cells (Figure 4.3). Since environmental endocrine disruptors 
are mostly hydrophobic, they are mainly adsorbed into the fat tissue. In the second 
version with 4 chambers (Figure 4.4), the fat chamber was taken off of the chip to 
simplify the design and to reduce the size of the chip. The silicon chip was 2.54 cm by 
2.54 cm in size, with a thickness of 525 um. Depth of the cell culture chambers were 
Fat 
Mammary 
Uterus 
Liver 
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35 um. The on-chip liquid to cell volume ratio was around 2 in this design. An ideal 
microfluidic cell culture device should reproduce in vivo like cellular micro 
environment where the physiological value of liquid to cell volume ratio is about 0.5. 
For monolayer culture it is difficult to obtain a ratio of 0.5 and leave sufficient space 
for fluid flow. For comparison, the liquid to cell volume ratio in traditional cell culture 
flasks and dishes is from 200 to 300. Hydrodynamic shear stress on cells was kept 
lower than 2 dynes/cm2  [25] by careful design of chamber geometry and fluid flow. 
 
 
 
Figure 4.4 (left) Illustration and (right) photo of the four chamber microCCA.  
 
Three cell lines were picked for on-chip cell culture. The HepG2/C3A cell line, which 
is a subclone of HepG2, was used as a model for the liver. This cell line has detectable 
CYP1A1/2, which are responsible for the metabolism of estrogens such as E2 and 
trans-stilbene. MCF7-GFP developed from MCF-7 cell line was used to imitate the 
mammary tissue. Ishikawa-GFP was developed from Ishikawa carcinoma cell line to 
represent the endometrial tissue. In the previous work on microCCA, cell responses 
were characterized mainly by cell viability and glutathione (GSH) depletion. Usually 
the cells were stained with live/dead molecular probes, such as Calcein AM and 
ethidium homodimer-1 (EthD-1) to indicate their viability and proliferation ability. 
Such assessment is only for end point measurement. The introduction of GFP reporter 
into the cell line allowed direct visualization of cell response to estrogenic and 
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antiestrogenic compounds without additional staining. In addition, cell responses can 
be monitored in real time or at multiple time points. The construction of MCF7-GFP 
and Ishikawa-GFP cell lines has been described in chapter two. In both cell lines, 
expression of GFP increases when cells are exposed to 10-11 M or higher 
concentrations of E2. 
 
 
 
Figure 4.5 Photography of the microCCA experimental setup. 
 
 
The culturing of cells on silicon devices has been described in several publications. 
Methods of silicon surface treatment varied with different cell lines to be cultured onto 
the silicon device. Poly-D-lysine and fibronectin have been used previously  in our lab 
to attach HepG2/C3A, bone marrow, and uterine sarcoma cell lines onto microCCA 
[26]. However, in this study, MCF7-GFP cells were found to aggregate when cultured 
on surfaces treated with poly-D-lysine. Cells piled up to each other and produce false 
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GFP signals. For this reason, only fibronectin was used to attach MCF7 cells onto the 
chip. 
 
Figure 4.5 shows a photograph of the experimental setup consisting of the microCCA 
chip coupled with a bulk peristaltic pump. The medium was aspired from the medium 
reservoir and was pumped through the bubble tip and the microCCA chip, then 
recirculated back into a reservoir containing 200 ul McCoy’ 5A medium. The pump 
has 8 channels. Thus 8 microCCA devices are usually operated in each test. 
 
4.4.2 Development of an in-line bubble trap 
Air bubbles entering a microfluidic cell culture device may occlude the fluid channels 
and displace cell culture medium in the culture chamber. Cell death may result from 
disruption of the cell membrane by surface tension of the air-liquid interface or from 
lack of liquid medium and nutrition, causing experiments to fail.  Long-term perfusion 
of microfluidic devices, such as the two to three days cell culture in microCCA 
devices, is very susceptible to bubble formation within the fluid network. Care is 
usually taken to fill microfluidic networks and connect tubing without introducing 
bubbles. For example, tubing should be rinsed with DPBS or medium prior to 
assembly to remove air from the tubing. However, bubbles sometimes nucleate within 
the tubing and it becomes difficult to remove them totally.   
 
There are several ways to debubble.  One method uses the buoyancy property of air 
bubble, which tends to float up in a liquid. However, most bubble traps are ineffective 
for microfluidic systems as these require tubing to connect the bubble trap to the 
microfluidic device, which introduces more opportunities for bubbles to enter the 
fluidic network.  In addition, the inner volume of such bubble traps is usually large (> 
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1 ml) while the liquid volume in microfluidic devices is usually small (about 250 ul in 
microCCA). The presence of such a big bubble trap would disrupt the fluid dynamics 
of the microfluidic system. The second type of debubbler or degasser involves 
membrane base hydrophobic venting [27]. But the pressure tolerance of the membrane 
is lower than the one that drive the liquid through the microCCA chip. The open holes 
in the membrane also present a threat for sterility.  
 
 
 
 
 
Figure 4.6 Working principle of the bubble tip. Small air bubbles were retained at the 
upper session of the bubble tip as indicated by the arrows. 
 
The in-line microfluidic bubble trap described here requires no extra tubing 
connection. It is inserted into the flow path and connected directly to the microCCA 
device.  It can be easily integrated into many microfluidic designs. Figure 4.5 
illustrates the working principle of the bubble tip. As small air bubbles enter the bulb 
of the bubble tip.  They tend to float up and accumulate at the upper half of the bulb 
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and form a small air pocket, while liquid would keep flowing down into the chip. 
Bubble tips should be standing upward to function well as a debubbler. This is usually 
easy to achieve as the bubble tip itself is stiff. Taping the tubing connected to the 
bubble tips onto the side wall of the peristaltic pump also helps. It should be noted that 
although this design worked well with our experimental design described here, it does 
have a limit on the volume of the air bubbles it tolerates. Too much air bubble entering 
the bubble tip would push down the liquid-air interface into the chip device and cause 
the experiment to fail.  
 
 
 
Figure 4.7  Responses of MCF7-GFP and Ishikawa-GFP cells cultured on microCCA 
chips to 1 nM E2, 1uM ICI 182.780 (ICI) mixed with 1 nM E2 and 1 uM raloxifene 
(Ral). 
 
4.4.3 Detection of estrogenic and antiestrogenic chemicals with microCCA  
E2 was used as a model chemical for estrogenic endocrine disruptors. In experiments 
that were carried on in a multi-well cell culture plate, 10-9 M E2 induced a strong GFP 
expression when compared to control samples after 48 h [18]. However, results were 
different when the experiments were carried on microCCA system with medium 
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recirculated by a peristaltic pump. No significant difference of the GFP intensity was 
observed between cells exposed to E2 and cells in the control group. Our previous 
study [28] suggested that the BPT tubing used with the peristaltic pump releases 
estrogenic contaminates.  The results from the microCCA are consistent with our 
previous findings. In this experimental setup, the length of the microbore (ID = 0.25 
mm) BPT tubing used was 55 cm. The inner volume is about 25 ul while the surface 
area is about 430 mm2. The large surface area to volume ratio in the tubing, as well as 
in the microCCA microfluidic device itself, contributed to the accumulation of the 
leached contaminates.  
 
 
 
 
 
Figure 4.8 Quantification of GFP intensities in MCF7-GFP and Ishikawa-GFP cells 
cultured on microCCA chips with 1 nM E2, 1uM ICI 182.780  with 1 nM E2 (ICI), or  
1 uM raloxifene with 1 nM E2 (Ral). 
 
When antiestrogens ICI and raloxifene were added into the medium together with E2, 
they exhibited different GFP-inhibiting profile in Ishikawa-GFP and MCF7-GFP cell 
lines. In MCF7-GFP cells, both ICI and raloxifene inhibited the expression of GFP 
(Figure 4.7).   In Ishikawa-GFP cell culture, ICI completely suppressed E2 induced 
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GFP expression. The GFP intensity also decreased with Ral treatments, but was not 
completely suppressed (Figure 4.7 and 4.8).   These results were consistent with our 
previous results, which showed that raloxifene was able to induce GFP expression by 
binding to estrogen receptors [18]; And raloxifene has a high affinity with the estrogen 
receptor and compete with E2 to bind to estrogen receptors, yet it is less potent than 
E2.  
 
 
 
 
Figure 4.9 The control system of the micropump with power supply and the stand-
alone program box. 
 
 
4.4.4 Development and characterization of the PDMS micropump 
To overcome the interference caused by contaminants leaching from BPT tubing, a 
micropump was developed to eliminate the use of the BPT.  The micropump consisted 
of three layers of PDMS plates; a top layer with medium/liquid channels, a PDMS 
membrane layer as the diaphragm, and the bottom layer with air chambers. Depth of 
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the medium channel and air chambers were 50 um. The thickness of the PDMS 
membrane was 35 um.  
 
The pump had three pneumatic microvalves that open and close via an applied air 
pressure (compressed nitrogen, 138 kPa) and vacuum (-103 kPa) regulated by a micro 
processor. The reason to use compressed nitrogen instead of other gases such as the 
carbon dioxide (CO2) and oxygen is due to the low permeability of PDMS to N2, as 
well as the inert nature of N2. The microvalves were controlled by a stand alone micro 
processor (Comat BoxX controller with LCD AF-10MR-D-LCD/24V) and three three-
port solenoids (S070M-5CG-32, SMC, Tustin CA) with a response time of less than 3 
ms and a maximum operating pressure of 0.3MPa (43.5 Psi) (Figure 4.9). The 
pneumatic valves were operated in sequence to work as a peristaltic pump (Figure 
4.10). The valves were programmed to open and close sequentially by following a 
pattern denoted by (100), (110), (011), and (001). The logical “1” is defined as the 
down motion of the PDMS thin membrane, and medium is draw into the chamber. “0” 
is defined as the up motion of the PDMS thin membrane, and medium is pushed out of 
the chamber. 
 
 
 
Figure 4.10  Illustration of the structure of the micropump at (001) state. 
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Figure 4.11 Spinning curve of PDMS. PDMS was mixed at ten parts of polymer 
precursor and one part of cross-linking agent by weight. Spinning time was 45 s. 
 
 
 
Figure 4.12 A graph plotting flow rate as a function of actuation frequency for the 
micropump with a flow channel depths of 50 um. Thickness of the actuation 
membrane was 30 um.  
 
 
Figure 4.11 is the measured spinning curve of PDMS that was mixed at ten parts of 
polymer precursor and one part of cross-linking agent by weight. The thickness of the 
PDMS membrane decrease as the spinning speed increased. The optimal thickness for 
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this application was chosen to be 30 um. A thicker membrane is less flexible and its 
actuation requires a higher pressure to drive. A thinner membrane may be less durable 
and are prone to defects. In addition, the PDMS need to be diluted in hexane for 
making membranes as thin as 12 um thick . 
 
 
Figure 4.14 A graph plotting flow rate as a function of actuation air pressure for the 
micropump. Depth of the flow channel was 50 um. Thickness of the actuation 
membrane was 30 um. Pumping frequency was 2 Hz. 
 
Flow output of the constructed micopump was show in Figure 4.12 and Figure 4.13. 
Figure 4.12 measured the pumping flow rate as a function of the actuation frequency. 
For a micro pump with the depth of the medium channel and air chambers being 50 
um and the thickness of the PDMS membrane being 35 um, the flow rate increased 
linearly with the pumping frequency up to 8 Hz. A 3.2 ul/min flow rate was obtained 
at 3 Hz frequency. This was the flow rate designed for the microCCA device described 
in section4.3.3.1. The pumping performance was also affected by the air pressure that 
was used to actuate the membrane as shown in Figure 4.13. With a pressure of 68.9 
kPa (10 psi) or lower, the deformation of the membrane was not sufficient to drive the 
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pump. On the other hand, an air pressure higher than 103 kPa (15 Psi) only increased 
the flow rate slightly as the deformation of the membrane reaches its maximal amount. 
 
 
4.4.5 Operation of the microCCA device with PDMS micropumps 
Figure 4.14 showed the final microCCA experimental setup with the PDMS 
micropump. The micropump may be placed under or by the side of the microCCA 
device. The total length of the PTFE tubing used with each microCCA device was 
about 8 cm and can be further shortened if necessary.  Four pumps were fabricated on 
the PDMS slab in Figure 4.14.  
 
 
 
Figure 4.14  Experimental setup of the microCCA device with a PDMS micropump 
 
In the previous microCCA experimental setup, a commercial peristaltic pump was 
used to recirculate the flow. Contaminations released from the BPT tubing used with 
the peristaltic pump caused GFP expression in both Ishikawa-GFP and MEF7-GFP 
cells. Length of the BPT tubing was about 55 cm. Here with the PDMS micropump, 
PTFE tubing replaced BPT tubing. And the length was greatly shortened as well to 
about 8 cm. Preliminary results from this micropump setup showed that no 
contamination caused GFP expression in Ishikawa-GFP cells after 48 h (Figure 4.15) 
in the control samples. Also estrogen induced increase of GFP expression was 
observed (Figure 4.15).   
microCCA  
micropump 
Reservoir 
Connections to pressure/vacuum 
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Challenges remained to integrate the micropump and microCCA devices together for 
long-term experiments (e.g. longer than 24 h).  The bonding between the three PDMS 
layers of the micropump needs to be strengthened. Currently the three layers were 
bonded together with air plasma surface treatment. Damage of the sealing and resulted 
pump leakage was sometimes observed with 48 h experiment setups. Oxygen plasma, 
instead of air plasma, has been reported to lead to better adhesion between PDMS 
layers, and may be tested when available. A partial curing method was demonstrated 
to be a considerable improvement in bond strength and consistency over oxygen 
plasma [29]. But our results indicated that this improvement is minimal and 
insufficient for our applications. In our setup the pump was driven by 140 KPa air 
pressure to overcome the resistance introduced by the microCCA and the fluidic 
recirculation system. Wider channels on the microCCA devices may help drop the 
pressure requirements, relieve the leakage problem and improve the pump 
performance.  
 
As PDMS surface is extremely hydrophobic, hydrophobic molecules, including 
hormones and proteins, are susceptible to irreversibly adsorption onto the surface. The 
responses of Ishikawa-GFP cells to 1uM E2 in Figure 4.14 was less strong than the 
cells responses observed in well plates, partially due to surface adsorption of E2 to 
PDMS surfaces. Several methods, including surfactant treatment [30], parylene 
coating [31], grafting of epoxy-modified hydrophilic polymers [32], have been 
reported in the literature to alleviate surface adsorption in PDMS based devices.  
However, our preliminary results from surfactant Pluronic® F-68 surface treatment 
showed no significant improvement.  Further investigations on this issue are needed to 
increase the sensitivity of assays based on PDMS devices. 
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Figure 4.15  Responses of Ishikawa-GFP cells on microCCA after exposure to (A) 1 
uM E2 and (B) control situation without estrogen for 48 h.   
 
4.5 Conclusions 
In conclusion, a prototype microCCA with a pneumatic micropump has been 
developed to demonstrate the detection of estrogens and antiestrogens with E2, ICI 
and raloxifene as model reagents. The in-line bubble tip allowed easy removal of fine 
air bubbles trapped in the fluidic pathways. The micropump improved the 
contamination leakage problem associated with a bulky traditional peristaltic pump. 
Multiple cell types and recirculation medium allow researchers to address tissue 
specific responses and potentially to study effects of drug metabolites in a dynamic 
system that mimics the time dependent changes in drug concentrations, and the 
microfluidic shear situation inside a human body.  This system is compact in size and 
relatively inexpensive to produce. The development of the microCCA and 
incorporation of the micropump may offer an advanced tool for fast and precise 
detection of estrogenic environmental endocrine disruptors, for screening of 
antiestrogen drug candidates, and for better prediction of the toxicity of such 
compounds. 
 
A                          B 
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CHAPTER 5 
 
DEVELOPMENT OF DISPOSABLE PDMS MICRO CELL CULTURE ANALOG 
DEVICES WITH PHOTOPOLYMERIZABLE HYDROGEL ENCAPSULATING 
LIVING CELLS 
 
5.1 Abstract 
In previous studies we have developed silicon based micro cell culture analog 
(microCCA) devices to address tissue-tissue interaction and for simultaneous toxicity 
assessment of multiple types of cells. However, the development of PDMS micro 
devices have been delayed due to the difficulty of seeding multi cell types into a 
closed PDMS device. Approaches with microvalves to control the flow are complex, 
expensive and inconvenient to use. Here we described a simple alternative way for 
patterning multi types of cells into individual cell culture chambers within a closed 
PDMS microCCA device.  Photopolymerizable hydrogels, with polyethylene glycol 
diacrylate (PEG DA) as a model prepolymer, were used for three dimensional (3D) 
cell encapsulations. A fluorescence microscope based direct pattern writing method 
was used for one-step cell encapsulation and hydrogel patterning. More than 90% of 
the cells remained viable after polymerization. The capability of such a PDMS 
microCCA device with hydrogel containing living cells as a biosensor was 
demonstrated with Triton X-100 as a model toxicant.  All cells on the microCCA 
device lost their viability after exposure to 0.02% Triton X-100. The combination of 
photopolymerizable hydrogels and the microfluidic cell culture device will make it 
possible to fabricate simple and low cost biosensors for drug development, 
environmental toxicity study and clinical diagnoses. 
 
127 
 
 
5.2 Introduction 
Poly (dimethylsiloxane) (PDMS) based soft lithography has become popular for the 
microfabrication of cell culture devices [1, 2]. Structures on a micrometer scale can be 
easily made with soft lithography requiring less complicated facilities than 
photolithography [3]. PDMS is inexpensive, bio-compatible, gas permeable, and the 
surface can be easily modified for cell attachment [4]. In addition, PDMS microfluidic 
structures can be easily sealed to a glass surface by introducing both the PDMS and 
glass into oxygen plasma to form a permanent bond. Both the glass and the PDMS are 
good supporting materials for cell adhesion and optical analysis. The overall cost of 
such devices is low enough for making disposable biological and medical devices to 
avoid cross contamination.  
 
Loading of cells into the PDMS micro devices usually involves three procedures: 
surface coating, cell seeding and medium rinsing. Poly-D-lysine, fibronectin, collagen 
and other components of extra cellular matrix or synthetic polymers are used to alter 
the surface charge and hydrophobicity or introduce binding sites for cells.  Cell 
suspension is then introduced into the channel or microfluidic pathway, and cells are 
allowed to attach to the inner surface of the device to form a monolayer for a typical 
time of four to eight hours. Cell culture medium is then introduced to rinse loosely 
attached cells, provide nutrition, and in many applications, to provide hydrodynamic 
forces necessary for specific cellular functions.  Cell loading, however, is usually 
performed after the PDMS-glass seal, as the cells would be damaged by the oxygen 
plasma.  Such an approach works well for attaching one type of cell, but it is difficult 
to obtain controlled spatial distribution of multi types of cells in a microfluidic device 
or accurate modeling of the cellular microenvironment. With a microfluidic system, 
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micro valves can be fabricated or incorporated into the device to manipulate the flow. 
By controlling the open/close state of each valve, cell suspension may be dispensed 
into only the destination chamber or area, but not the other area of the device [2, 5]. 
However, this method requires a complicated control system with a lab view interface. 
And the introduction of micro valves not only increases the cost and difficulty of 
operation, but also interferes with the microfluidic system, for example, by increasing 
the dead volume in the culture device.   
 
Another approach skips the PDMS-glass bonding process. Instead, cells are seeded 
onto a PDMS slab by direct cell seeding onto a specific area or facilitated by micro 
contact printing. However, extra peripheral components such as bulky housing pieces 
are necessary to enclose the PDMS slab to form a close system.  Cell co-culture is 
necessary to study cell interactions. Coculture of cells also has been found to enhance 
differentiation and improve expression of in vivo functions of cells cultured in vitro 
[6-8]. In addition, coculture of multi type of cells within different compartments of a 
device is the concept behind a microCCA device, which is a physical replica of the 
human body with different cell lines cultured in different organ or tissue 
compartments to represent each organ. A liver compartment is usually included to 
study drug metabolism, including the effect of metabolites on target tissues. The 
current microCCA devices are made from silicon and a Plexiglas housing is used to 
form a close fluidic structure. A novel method is needed to enable devices, like the 
microCCA, to be made with PDMS/glass and become disposable. A challenge is to 
load multi types of cells into different compartments of a closed PDMS device.   
 
3D cell cultures provides more physiological relevant cellular environment than 
traditional 2D cell culture, and also protect cells from hydrodynamic forces. Cells are 
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usually encapsulated in porous materials or in hydrogels. Porous materials are most 
often used as temporary supporting structure to from artificial tissue, and degrade with 
time under physiological conditions. Porous polymers such as polylactic acid (PLA), 
polyglycolic acid (PGA), poly (lactic-co-glycolic acid) (PLGA) are constructed with 
various pore sizes to house cell cultures. Hydrogels are three-dimensionally cross-
linked macromolecules of hydrophilic polymers. Hydrogels are high in water content,   
and possess a degree of flexibility very similar to natural tissue. "Naturally based" 
hydrogels such as Matrigel (made of native extracellular matrix proteins, ECMs), 
collagen (the major extracellular matrix protein), gelatin and hyaluronic acid provide 
endogenous signals that promote the cellular interactions that underlie tissue 
formation. ECMs contain essential proteins that help cells attach, grow and 
differentiate. Some other examples of natural hydrogels include dextran and alginate. 
Hydrogels to mimic the extracellular matrix can be created from synthetic molecules 
such as poly (ethylene glycol), polyglycolide, polylactide, acrylamide derivatives, 
calcium alginate and agarose [9, 10]. These polymers are cross-linked using ultraviolet 
light, radioactive rays, chemical cross-linking agents, ion solutions, or via temperature 
control for thermo-responsive hydrogels to reach a three-dimensional form. The 
advantages of synthetic gels include their consistent composition and predictable 
manipulation of mechanical, chemical and physical properties such as hydrophobicity, 
as well as degradability that can be tailored for different applications. However  these 
gels often lack functional sites to interact with soluble or cell-surface proteins [11]. 
Proteins and positive charged components are often added into the composition to 
support cell-gel interactions. Cells are usually incubated within the polymer during 
this process and remain encapsulated after the gel is formed. 
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Although hydrogels are soft in texture and easy to handle at microliter scale, 
generation of micro structures of hydrogels containing living cells with controlled 
spatial distribution can be challenging, mainly because of the limitation of 
crosslinking methods. It is preferred that gel formation occurs at physiological 
temperature and pH to enhance maintenance of cell function. The crosslinking process 
is required to occur in the micro device rather than being transferred into the micro 
devices due to the difficulty of handling soft microscale gels.  
 
Recent advances in hydrogel technology can support this objective. The gel may be a 
bulky slab or have microstructures in an array within a microfluidic network. To form 
a hydrogel slab in a microchannel, Frisk et.al injected Matrigel into a channel. The 
gelling process at 37°C caused Matrigel to shrink and generate a gap between the 
ceiling of the channel and the bulk hydrogel for medium perfusion [12]. Laminar flow 
has been used to partition microchannels with multiple microslabs of matrigels [13]. 
For micropatterning of hydrogels, gels may be deposited onto a surface by spinning, 
molding [14], or with a jet printer [15]. In addition, PDMS stamps have been used for 
micro contact printing of thermally curable gels and synthetic sol-gel transition 
peptide hydrogels such as Puramatrix [16].   
 
A most interesting method, however, is to use ultraviolet (UV) light to pattern 
photopolymerizable hydrogels. The most obvious advantage of photo crosslinking is 
that no contact between the crosslinking tool, here the light source, and the precursor 
solution is required, which allows the manipulation of the crosslinking process in a 
closed PDMS device through the PDMS or glass layers. Examples of polymers that 
can be UV crosslinked include polyethylene glycol diacrylate (PEG DA), dextran 
acrylate, and Pluronic™-DA. PEG [17], Pluronics [18]  and certain dextrans [19] are 
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FDA-approved for use in medical applications. PEG hydrogel microstructures were 
reported in 2000 to form active hydrogel components for self-regulated flow control 
[20]. A minimum feature size of 25 um, which was coincided with the minimum 
resolution of the photomask, was stated. 
 
Using PEG, Revzin et.al reported the formation of micro structures as small as 7-10 
um diameter [21]. PEG hydrogels encapsulating living 3T3 fibroblast were also 
generated by spin coating of cell-polymer precursor solution onto a glass substrate and 
then exposing the layer to 365 nm UV light through a photo mask [22].  Koh et.al also 
reported the fabrication of microstructures with 100 um diameter in a microfluidic 
channel or a single chamber with macrophage or fibroblast [23]. An cell microarray 
was also formed by PDMS molding [14]. Liu and coworkers was able to photopattern 
hydrogels of multiple cellular domains into a single "hybrid" hydrogel layer, and 
patterns of multiple cell types in multiple layers simulating use in a tissue engineering 
application [24]. PEG hydrogels was also constructed in microfluidic systems as 
functional components for pH sensing [25], and this technique may be possibly used 
for controlled release or delivery of small hydrophobic drugs [26]. A closed 
microfluidic network also promotes photopolymerization by limiting oxygen 
availability since oxygen was found to inhibit photopolymerizations [27]. With a 
photomask was inserted into the field–stop of the microscope to be used for 
projection, features down to 400 nm can be achieved with PEG polymeric particles 
[28], while photopatterned hydrogels microstructures containing living cell can be as 
small as 100 um feature size [29]. By combing photo- and electro patterning methods, 
Albrecht et.al was able to fabricate living cell arrays and position cells within a 
prepolymer solution prior to crosslinking and forming cell patters with micro 
resolution [29].  
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In this work, we present an approach using photopolymerizable hydrogels for 
patterning cell cocultures in a three compartment PDMS micro cell culture analog 
device.  We are the first to pattern different cell types into multi compartments of a 
microfluidic network.  The use of UV crosslinking technique eliminates the necessity 
to incorporate complex microfluidic control components, such as valves and multi 
inlets/outlets to control spatial specific cell seeding. PEG-DA was used as a model 
polymer as it is a well known hydrophilic, biocompatible material. It is usually used 
for surface modification of biomedical devices. In addition to micropatterning with a 
photomask and a UV spot light source, a direct writing method with UV light from a 
standard fluorescence microscope is described. As a demonstration, cells encapsulated 
in the microgels in a microCCA device were challenged with Triton X-100, and the 
change of cell viabilities was observed. The methods described here may contribute to 
the development of low cost and disposable multi-cell-based biosensors for both clinic 
and research purposes.    
 
5.3 Materials and methods 
5.3.1 Chemicals and reagents  
Unless mentioned otherwise, chemical reagents were purchased Sigma-Aldrich Corp. 
(St. Louis, MO). Fetal bovine serum (FBS) was from Hyclone (Logan, UT). PDMS 
prepolymers were from Corning Inc. (Corning, NY). CellTracker™ Green CMFDA 
(5-chloromethylfluorescein diacetate, CellTrace™ calcein blue AM, SYTO® 59 red 
fluorescent nucleic acid stain and the live/dead cell viability kit were from Invitrogen 
(Carlsbad, CA).PEG-DA was dissolved in phosphate-buffered saline (pH 7.4, 
Invitrogen; Carlsbad, CA). The photoinitiator, 2-hydroxy-1-[4-(hydroxyethoxy) 
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phenyl]-2-methyl 1-propanone (Irgacure 2959; Ciba, Tarrytown, NY) was dissolved  
in DMSO.  
 
To synthesize PEG-DA (MW 4000), 4.0 g (1 mmol) were dissolved in 100 ml of 
benzene and heated to 45C with stirring until a complete dissolution. After the 
solution was cooled to room temperature, 10.5 mmol of triethylamine, at a 
concentration five times molar excess of each –OH group on PEG4000, was added to 
the PEG solution. Then 10 mmol of acryloyl chloride, also at a concentration five 
times molar excess of each –OH group on PEG4000, was added dropwise to the 
PEG4000 solution to form acrylate diesters of PEG4000. The mixture was stirred at 0 
oC (ice bath) for 24 h under nitrogen atmosphere. The insoluble triethylamine salts 
formed during the reaction were removed by filtration and the PEG-DA 4000 product 
was precipitated in 500 ml chilled hexane and collected by filtration. Further 
purification was performed by redissolving in 20 ml of benzene and reprecipitated in 
500 ml of chilled hexane twice. The PEG-DA 4000 polymer was finally dried for 24 h 
in vacuo oven at room temperature and stored at 4C for future use.  
  
5.3.2 Cell culture  
MCF7cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) (MP 
Biomedicals, Solon, OH) supplemented with 5% heat inactivated FBS. Ishikawa Cells 
have been maintained in Minimum Essential Medium (MEM) (Invitrogen, Carlsbad, 
CA) with 10% FBS.  HepG2/C3A cells were obtained from the American Type 
Culture Collection (Manassas, VA), and were maintained in MEM with 1.0 mM 
sodium pyruvate and 10% FBS. All the cells were cultured at 37°C in a humidified, 
5% CO2, 95% atmosphere incubator. 
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5.3.3 Design and fabrication of PDMS microCCA device 
PDMS microCCA devices were designed based on a simplified PBPK model of the 
human body. The body is divided into liver, mammary gland, uterus, and the other 
tissues which include tissues non-reactive and non adsorbing tissues.. Parameters, such 
as blood flow rate, residence time, etc are obtained from the literature. Physical 
parameters of each chambers and channels are carefully adjusted and calculated to 
balance the pressure drop between medium inlet/outlet, to maintain the residence time 
consistent with in vivo situations. The widths of the channels were designed to be 
wider than that in the silicon based microCCA devices described in chapter 4 for easy 
introduction and clearance of the polymer precursor solution.   
 
PDMS microCCA devices were fabricated by PDMS molding from SU-8 masters. An 
SU8 mold master is fabricated by spinning SU8 2075 (MicroChem Corp., Newton, 
MA) onto silicon wafer at 500 rpm for 5 s then 1250 rpm for 30 s to reach a 200 um 
thickness of the SU8 layer. The resist layer was baked at 65°C for 10 min, 95°C for 40 
min, and then was exposed to UV light (405 nm) with a Hybrid Technology Group's 
system III-HR contact/proximity mask aligner (HTG) (San Jose, CA).  for 50 s and 
baked at 65°C for 5 min, 95°C for 20 min and 65°C for another 1 min. Development 
was done by immersing in SU8 developer (MicroChem Corp., Newton, MA) for 
several min to remove non-irradiated SU8 on the wafer. The mold was then treated 
with FOTS, also known as (1H, 1H, 2H, 2H-Perfluorooctyl) Trichlorosilane, as a 
release layer.   
 
135 
 
To make PDMS devices, a 10 1 w/w-mixture of monomer and hardener (Sylgard 184, 
Dow Corning) was degassed under vacuum for 10 min to remove air bubbles in the 
PDMS mixture. The PDMS layer was cured by baking at 65°C for 2 h. The device was 
peeled off the master and holes were punched as the inlet and outlet with a needle. For 
permanent boding of PDMS and glass, both PDMS and borofloat glass wafer 
(d=100mm) (Mark Optics, Santa Ana, CA) were treated with a oxygen plasma 
machine (Harrick Plasma, Ithaca, NY) for 40 s before contact. Tubing was inserted 
and PBS was introduced into the device immediately after the oxygen plasma 
treatment to help maintain the hydrophilic property of the channel inner surface. 
5.3.4 Surfaced treatment of PDMS devices 
For patterning hydrogels on glass slides (Mark Optics, Santa Ana, CA), the glass 
substrates were first treated with 3-Methacryloxypropyltrichlorosilane (MAOPTS) 
(RF 60 s, reaction 600 s) on a Molecular Vapor Deposition tool (MVD100, Applied 
Microstructures Inc., San Jose, CA). MAOPTS is a useful monolayer for creating 
surface functionalization to promote the polymer adhesion to the glass slide.  
For the microCCA device, surface treatment was performed after the bonding between 
PDMS and the glass substrate as described in the literature [21, 23]. In brief, the inner 
surfaces of microchannels were treated for 5 min with a 1 mM solution of MAOPTS 
in a 4:1 ratio of heptane-carbon tetrachloride, followed by washing with hexane and 
water. 
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5.3.5 Photopatterning of hydrogels  
5.3.5.1  Photopatterning of hydrogels with a photomask 
Photomasks were made by direct printing on a transparency film at 5080 dpi with a 
high resolution printer (Pageworks, Cambridge MA). The prepolymer solution was 
prepared to contain 15 % or 20% w/v PEGDA 700 or PEGDA 4000 and 20 × 106 cells 
mL–1 in PBS. Then Irgacure 2959 photoinitiator was added into the prepolymer 
solution at 0.1% w/v before UV exposure.  To generate patterns on a glass slide, 8 ul 
of the pre-polymer solution was pipette onto a flat polypropylene surface. Then 180 
um thick glass pieces were used as spacers, which determined the thickness of the 
precursor solution.  The precursor droplets were then covered with a glass cover, with 
the MAOPTS treated side facing down. A photomask was aligned over the precursor 
solutions and then exposed to 365 nm UV light (UVP Black-Ray, long wave UV spot 
lamp, Upland, CA) for 120 s.  Polymerization time varied depending on polymer 
composition. PEG prepolymer solution crosslinked covalently via radical chemistry 
upon UV exposure. After UV polymerization, uncrosslinked precursor solution was 
rinsed off with PBS. 
 
For microCCA, the prepolymer solution was injected into the cell culture chambers 
via the inlet hole using a syringe. A photomask was secured on top of the chamber 
with emulsion side facing the glass. Foil was used to cover or reveal individual cell 
culture chambers for UV exposure. The remaining uncrosslinked prepolymer solution 
and cells were then flushed from the chamber with PBS. To add additional cell types 
in the mammary chamber, the next cell/prepolymer solution was injected into the 
chamber and pumped around already crosslinked hydrogel microstructures followed 
by UV exposure.   
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5.3.5.2 Patterning with direct writing on a fluorescence microscope  
For direct pattern writing into the microCCA device, the prepolymer solution was 
prepared and injected into the cell culture chambers in the same way as patterning 
with a photomask. Instead of using a UV spot lamp for exposure, an inverted 
microscope was used to directly write the pattern onto the substrate.  The microCCA 
device was positioned onto the sample stage of a fluorescence microscope (Olympus 
America Inc., Center Valley, PA) and exposed to UV with a 40 X objective (Olympus 
SPlan 40 PL, NA 0.40). A DAPI filter set (Chroma Technology Corporation, 
Rockingham, VT) was used to select the desired wavelength. Typical exposure times 
used were 1 to 3 s. Patterns within a chamber were written by moving the sample 
stage. The remaining uncrosslinked prepolymer solution and cells were then flushed 
out of the chamber with PBS. To pattern hydrogel microstructures encapsulating 
HepG2/C3A cells into the liver chamber, prepolymer solution mixed with cells was 
then injected into the chamber followed by UV exposure. The direct writing procedure 
was repeated in the mammary and uterus chambers with respective cells. 
 
5.3.6  Live/dead cell viability assay 
Cell death was monitored using a Live/Dead Cell viability/cytotoxicity kit (Invitrogen, 
Carlsbad, CA) to analyze cell viability after encapsulation. In this assay, the 
intracellular esterases of the live cells convert the non-fluorescent calcein 
acetoxymethyl (calcein AM) to a fluorescent calcein. EthD-1 enters the dead cells 
through the damaged membranes and becomes fluorescent when bound to nucleic 
acids. Calcein AM dye produces a bright green fluorescence in live cells, whereas 
EthD-1 produces a bright red fluorescence in dead cells. 
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5.3.7 Optical imaging  
Cells were observed and imaged under an IMT-2 phase contrast and fluorescence 
microscope. Fluorescence and transmission images were captured with a Retiga CCD 
camera (Qimaging, Burnaby, BC, Canada) in a 12 bit grayscale format, and were 
analyzed using ImagePro Plus software (Media Cybernetics Inc., Silver Spring, MD). 
The fluorescence intensity in cells was calculated as the average optical density per 
pixel of cells. The optical cubes used for CellTracker™ Green CMFDA,  CellTrace™ 
calcein blue AM and SYTO® 59 were fluorescein isothiocyanate (FITC), 4'-6-
Diamidino-2-phenylindole (DAPI) and tetramethylrhodamine isothiocyanate (TRITC) 
cubes.  
 
5.4 Results and discussions 
5.4.1 UV polymerized hydrogels for cell culture  
 
 
 
 
 
Figure 5.1 Structure of (A) poly(ethylene glycol), (B) poly(ethylene glycol) diacrylate  
(PEG-DA) and (C) Pluronic F127-DA and F68-DA 
 
A                                   B 
 
C 
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In this work, PEG-DA was used as a model polymer tested for its capability for 
encapsulating cells in a microCCA device. The method described here, however, is 
useful for all other photopolymerizable polymers, such as Pluronic ® DA[30] and 
dextran-acrylate [31] (Figure 5.1). The polymerization process involves the induction 
of free radicals through photo initiators. The formation of hydrogel microstructures 
from polymer acrylates was based upon the UV initiated free-radical polymerization 
of acrylate end groups. The photoinitiator dissociates upon exposure to UV radiation, 
creating highly reactive methyl and benzaldehyde radicals, which then attack 
unsaturated carbon-carbon double bonds of acrylate functionalities on the macromer, 
thus initiating free radical polymerization results in the formation of a highly cross-
linked network. This network represents a three-dimensional, insoluble structure, 
capable of entrapping proteins [21] as well as live cells inside the gel matrix. 
 
Only recently have photopolymerizable hydrogels been used for live cell 
encapsulation and culture [22]. The advantage of using photopolymerizable hydrogels 
is that the patterning requires no direct contact of the light source and the patterning 
surface. Cells can be encapsulated into hydrogels via UV light through a glass slide, 
plastic cover, PDMS pieces, or other materials that are UV transparent. The 
mechanical properties of the hydrogels formed after UV exposure is affected by the 
structure of the precursor, concentration of the prepolymers, exposure time as well as 
the dimensions of the final gel. Viability of the cells inside the hydrogel after 
polymerization can be affected by parameters of the UV exposure, which also 
determines the resolution of the final features in the patterned hydrogel. A powerful 
UV source is favorable for faster gelling, yet the high power may also lead to cell 
damage, while a low energy source may cause a loss of resolution due to radical 
diffusion.  A long time UV exposure ( > 5 min) may also cause thermal damage. 
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Figure 5.2 PDMS based three chamber microCCA device. Fluidic pathways were 
visualized with green food dye. The three chambers represent the uterus tissue, liver 
and mammary tissue respectively (from left to right). 
 
5.4.2 Construction of the microCCA device 
Silicon based multi-chamber cell culture analog devices have been constructed 
previously in our group [32-34], and a microCCA device with four culture chambers 
has been described in Chapter 4.  However, silicon based micoCCA devices have 
several disadvantages. It is costly for making prototypes due to the high cost of silicon 
wafer and the photolithography fabrication process in a clean room. Furthermore, in 
order to enclose the microCCA device into a microfluidic system, a housing made 
from hard plastic is machined to contain the device and to connect the device to an 
external pump or a fluid handling system. Excellent sealing between the housing, the 
silicon chip and the tubing connections is required, which makes the assembly process 
difficult and variable due to personal practices. And chemical cross contamination is a 
problem when housing pieces are reused, as plastic is prone to chemical adsorption. A 
PDMS microCCA device, instead, is lower in cost, less expensive to fabricate, and 
easy to seal by plasma treatment and require no extra housing.   In addition, silicon is 
opaque while PDMS is optically transparent. 
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In this work we designed and fabricated a new version of a PDMS based microCCA 
device (Figure 5.2). The devices are meant to be disposable. The new design is a three 
chamber cell culture device with relatively wider channels to facilitate precursor 
solution removal after photo crosslinking. Pillars were used at inlets to improve 
mixing and for even chemical distribution across the chamber.  The depth of the 
chambers were 50 um or 175 um. The device was 2.5 cm x 2.5 cm in size. Thickness 
of the device is about 2.5 mm to 5 mm as determined by the thickness of the PDMS 
slab. A short PDMS cure time of 1.5 to 3 h worked well while a baking time longer 
than 24 h may cause PDMS to stick to the SU8 master, and break at elbows and at 
other small features. 
 
The three chambers represent the uterus tissue, liver and mammary tissue respectively. 
Three cell lines were picked for on-chip cell culture. The HepG2/C3A cell line was 
used as a model for the liver. This cell line has detectable CYP1A1/2 activity, which is 
responsible for the metabolism of estrogens such as E2 and trans-stilbene. MCF7-GFP 
developed from MCF-7 cell line was used to imitate the mammary tissue. Ishikawa-
GFP was developed from Ishikawa carcinoma cell line to represent the endometrial 
tissue. GFP intensity in MCF7-GFP and Ishikawa-GFP cells increase  when the cells 
were exposed to estrogens [35]. 
 
5.4.3 Photopatterning with a UV lamp 
UV spot lamps are commonly used to photopolymerize hydrogels [14, 21, 23, 25]. A 
photomask was aligned on top of the precursor solution for selective UV exposure. 
Figure 5.3 shows arrays of cylindrical microstructures with a diameter of 300 um 
created from PEG-DA700. The thickness of the gels was about 175 um, which is 
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adjustable by controlling the thickness of the spacer between the two pieces of cover 
glass.  
 
Uncrosslinked precursor solutions were rinsed off with PBS.  However, the PEG 
microstructures were easily disturbed and displaced during this rinsing process. 
Surface treatment with MAOPTS was able to form a mono layer of MAOPTS and 
leaves free methacrylate groups on the surface of the glass slide, which react with  
PEG-DA during UV crosslinking and promote the adhesion of PEG microstructures to 
the glass slide  [21].  
 
A UV lamp doses a large working area and allows the generation of many 
microstructures all at once. However, in our setup the exposure time required for 
gelling was relatively long, with 2 min exposure required for PEG 700 and 3 min for 
PEG 700/DA / PEG 4000/DA mixtures.  The cell viability was greatly affected by 
polymerization with less than 50% of the population being viable (data not shown). In 
addition, since the light from the spot lamp was divergent, the polymerization speed 
was affected greatly by the position of the precursor solution in relative to the light 
source.  It was challenging to use this system to generate consistent data.  
 
 
 
 
Figure 5.3 PEG/DA 700 microstructures generated with photopatterning with a UV 
lamp. Diameter of each cylindrical microstructure was 300 um. 
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5.4.4 Photopatterning with a fluorescence microscope 
A fluorescence microscope is readily available in most biology labs and provides an 
alternative source for UV polymerization. A DAPI filter cube allows the light with 
wavelengths of 340 ± 40 nm to pass through, which is the range for UV light induces 
the PEG polymerization process. The lens narrow the light beam and providers a high 
light intensity near the focus point, which results in a fast photocrosslinking speed. 
The typical exposure time that was required for PEG crosslinking with a UV spot 
lamp was 2 min to 5 min while 0.5 s to 3 s was necessary on a fluorescent microscope. 
The diameters of the PEG dots generated near the focus with a 40 X objective were 
measured to be 400 um to 600 um. 
 
A second advantage of using the fluorescence microscope for UV crosslinking is that 
it allows real-time monitoring of the polymerization progress. As the precursor 
solution is exposed to the UV light through a DAPI filter cube, the cell status and 
formation of the hydrogel may be observed simultaneously through transmission light 
microscopy or through fluorescence dyes if the dye spectrum fits that of the DAPI 
cube. Figure 5.4 shows the UV crosslinking process with PEG to encapsulate Ishikawa 
cells. The PEG700 hydrogel was observed to have clear borders visible in both 
transmission and fluorescence images, which stood out and separated it from the 
surrounding uncrosslinked precursor solution, even before the PBS rinsing. The red 
fluorescence of the cells is from SYTO 59 probe and was observed by changing the 
optical filter cube.  However, it is possible to observe the fluoresce at the same time 
the hydrogel is being formed when blue fluorescent dyes, such as DAPI, Calcein blue 
AM and CellTracker™ blue that fit the DAPI filter cube, is used to visualize live cells 
or other cell functions. 
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Figure 5.4  Encapsulation of Ishikawa cells in PEG DA 700. (A) and (B) are 
transmission images and (C) to (E) are fluorescent images. Cells were stained with 
SYTO 59 for visualization purpose. (C) Precursor solution was injected into the cell 
chamber. (A) and (D) Gel was formed upon UV exposure. (B) and (E) Rinsing with 
PBS removed uncrosslinked prepolymer solutions as well as loose cells around the 
hydrogel structure. These images show that with PEG DA 700, the polymerization 
progress can be monitored in real-time. 
 
The diameter and the thickness of the hydrogel dots were affected by the time of 
exposure. Figure 5.5 showed the PEG/DA 700 hydrogel microstructures formed with a 
A 
 
 
 
 
 
B 
C 
 
 
 
 
 
D 
 
 
 
 
 
E 
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fluorescence microscope. The diameters of the dots for 1 s, 2 s, 3 s and 4 s exposure 
were measured to be about 400 um, 500 um, 550 um and 600 um, Increase of exposure 
time also increased the thickness of the hydrogel microstructures.  
 
 
 
 
Figure 5.5  Effect of UV exposure time on the size and thickness of the formed 
hydrogel. The UV exposure time for the polymerization was 1 s, 2 s, 3 s and 4 s 
respectively from left to right.  
 
To demonstrate the capability direct pattern writing with a fluorescence microscope, 
letters were written onto a glass substrate. Figure 5.6 are images of the written pattern, 
the letter C and letter U, generated with PEG700/4000 DA with live cells encapsulated 
in the gel. The letters were written by moving the sample stage of the fluorescence 
microscope manually. In Figure 5.6 A, the hydrogel was stained with green food dye 
to visualize the letters. Figure 5.6 B is the fluorescence photo of same hydrogel 
structure, where cells were stained with SYTO 59 that bind to nucleic acid and 
generate a red fluorescence.  
 
Although several groups have used a fluorescence microscope as a UV source to 
crosslink hydrogels, the patterns were generated with a photo mask rather than with 
direct writing [20]. Direct writing with a microscope allows easy control over a single 
hydrogel microstructure. As shown in Figure 5.6, the individual hydrogel 
microstructures can be placed separated, adjacent or overlapping to each other. This 
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method may be combined with an automatically controlled microscope sample stage 
for precise cell placement to study migrations, cell-cell and cell-biomaterial 
interactions. The size of the hydrogel dots generated with our current optical setup 
were relatively large ( ~ 400 um), but may be reduced with different objectives and 
optimized optical setups.  
 
 
 
  
Figure 5.6 PEG/DA 700/4000 microstructures generated with direct pattern writing on 
a fluorescence microscope.  
 
5.4.5  Patterning multi types of cells inside a microCCA device 
Photocrosslinking enables polymerization without direct contact between an “inducer” 
and the prepolymer solution. Hydrogels with different compositions can be formed at 
specified sites very close to each other. Such a property allows patterning of multi 
types of cells in one chamber or in different chambers that are connected together in a 
microCCA device.  
 
Figure 5.7 is an image demonstrating the patterning of three different hydrogel 
microstructures adjacent to each other in a chamber of 8 mm by 8 mm. Ishikawa cells 
were mixed with PEG 700/4000 DA  (v/v 1:4) precursor solution, and then stained 
with either CellTracker Green, Calcein blue AM or SYTO 59 red.  Precursor solutions 
A                                          B 
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with cells stained green were first injected into the liver chamber and a hydrogel dot 
was formed by direct UV writing through an objective with a DAPI filter cube. Then 
the PBS was injected into the chamber to rinse off loose precursor solutions. Then the 
sample stage was moved and same procedures were repeated with precursor solution 
mixed with Ishikawa cells stained blue and that with cells stained red to form hydrogel 
dots at different spots. 
 
 
 
 
Figure 5.7 Copatterning of multi-types of cells in a microfluidic cell culture chamber. 
Ishikawa cells were stained with CellTracker™ Green, CellTrace™ calcein blue AM 
and SYTO® 59 red fluorescent nucleic acid stain respectively. The gel dots were 
formed with a DAPI filter on a fluorescence microscope. 
 
 
400 um 
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With the same method, three types of cells were patterned into individual cell culture 
chambers of the microCCA device described in section 5.4.2. HepG2/C3A cells 
encapsulated in PEG 700/4000 were patterned into the liver cell culture chamber, and 
Ishikawa cells and MCF7 cells were patterned into the uterus and mammary cell 
culture chambers respectively (Figure 5.8).  
 
 
 
 
 
 
Figure 5.8  Patterning of three different type of cells in a microCCA  device. Ishikawa, 
HepG2/C3A and MCF-7 cells were encapsulated into the hydrogel dots inside the 
uterus, liver and mammary cell culture chamber respectively. The hydrogels were not 
visualized very clearly due to their small size and transparent nature. 
 
MAOPTS treatment of the glass slide was used for promote adhesion of the PEG 
hydrogel to the glass surface after UV exposure. Without surface modification, the 
formed hydrogel microstructures do not bind effectively to the glass surface and easily 
detach from the glass surface with PBS rinsing. However, in a PDMS based 
microCCA device, we found that MAOPTS treatment was not necessary, likely due to 
the fact that the formed microhydrogel was sandwiched between the PDMS and the 
cover glass. Results from our experiment showed no displacements of the formed PEG 
Uterus 
Liver 
Mammary 
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700 or PEG 700/4000 hydrogel dots when PBS rinsing was performing manually or 
with a pump with flow rates less than 2 ml per min.  
 
5.4.6  Cell viability measurements 
The viability of Ishikawa cells were assessed before and 30 min after the 
polymerization process. We observed a more than 50% of cell death after UV 
crosslinking with a UV spot lamp (UV exposure time 2.5 min) (data not shown). With 
direct writing using a 40 X, no obvious decrease of cell viability after UV crosslinking 
(UV exposure time 2 s) was observed (Figure 5.9). The improved cell viability may 
result from the significant decrease of the UV exposure time with the direct writing 
method.  
 
Others have reported better cell viabilities ( > 80% viable cells) after polymerization 
with a UV spot lamp [22, 23, 29]. Part of the reason may be the difference of cells 
types used in each study, as fibroblasts [22, 23, 29] and endothelial cells used in this 
study may have various sensitivity to UV and free radical induced damages. It has 
been discovered previously that endothelial cells display lower antioxidant enzyme 
activities,  are inherently more sensitive to the harmful effects of reactive oxygen 
metabolites [36] and oxygen toxicity [37] than fibroblasts. 
 
5.4.7 Responses of PEG encapsulated cells in microCCA devices 
The microCCA with cells encapsulated in PEG may be used as biosensors to detect 
toxins. Here we used Triton X-100 as a model reagent.  Triton X-100 is a non-ionic 
surfactant, which is widely common for the solubilisation of membranes under non-
denaturing conditions [38]. Exposure to Triton X-100 may induce a rapid cell death by 
necrosis caused by the permeabilisation of the cell membranes [39].  
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Figure 5.9  Viability of Ishikawa cells (A), (B) in  the control samples and (C), (D) in 
a three dimensional hydrogel microstructure 30 min after photopolymerization. (A) 
and (C) showed live cells stained bright; (B) and (D) showed dead cells. Control 
samples were uncrosslinked precursor solution mixed with cells.  
 
Ishikawa and HepG2/C3A cells were first patterned into the uterus chamber and the 
liver chamber via direct pattern writing in microCCA devices. Viability of these PEG 
encapsulated cells patterned were measured after 20 min exposure to 0.02% Triton X-
100. Results showed that both HepG2/C3A cells and Ishikawa cells were 100% dead 
while more than 90% of the cells remained live in the control samples (Figure 5.10). 
This result indicating that (1) Triton X-100 may readily diffuse into the micro 
hydrogel structure; (2) Cells encapsulated within the microhydrogel structures retained 
their viability and metabolic active; (3) The microCCA with PEG encapsulated cells 
A                       B 
C                      D 
Live                           Dead 
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was capable of simultaneous assessment of chemical toxicity with multiple types of 
cells.    
 
 
 
 
Figure 5.10  Viability of hepatocytes HepG2/C3A cells and endometrial Ishikawa cells 
in the control samples or in samples with 0.02% Triton X-100. Cells were 
encapsulated inside PEG 700/4000 and patterned into microCCA chambers. 
 
Crosslinking of photopolymerizable prepolymers form a 3D network within the 
hydrogel. Heavily crosslinked hydrogels have smaller values of mesh size and number 
average molecular weight between crosslinks, which lead to a decreased mass transfer 
of molecules. For example, Ricin (MW 60000) failed to penetrate into the PEG DA 
(MW 575) hydrogel in a study [23]. PEG DA with a larger molecular weight, such as 
PEG DA (MW 4000), is preferred when working with large molecular compounds. 
Solute diffusion within a hydrogel should be carefully investigated when designing 
photopolymerizable hydrogels for a specific application, especially when large 
macromolecules are involved.   
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5.5 Conclusion 
In this work we developed a new method for direct patterning of different types of 
cells into different chambers in a closed PDMS microfluidic cell culture device. 
Ishikawa, MCF-7 and HepG2/C3A cells were patterned into their individual cell 
culture chambers, and the cells maintained good cell viability after UV 
polymerization.  The encapsulated cells in microCCA responded well when exposed 
to a model reagent, Triton X-100.  Although PEG was used as a model polymer in this 
study, the method is versatile and is suitable for other photocurable polymers such as 
dextran-DA.  The method described here allows us to design and fabricate low-cost 
and disposable multi type-cell based biosensors, including the PDMS microCCA 
device described here, for drug screening and environmental toxin detections.  A more 
useful system may be constructed in combine with other hydrogel based techniques, 
such as functional hydrogel structures for autonomous flow control [20] and intra 
channel pH sensing with PEG patch [25]. 
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CHAPTER 6 
 
CONCLUSIONS AND FINAL RECOMMENDATIONS 
 
6.1 Conclusions 
A dual cell-line GFP expression system was constructed to study endocrine disrupting 
compounds with activities of estrogen receptor agonists or antagonists. The two stable 
cell lines, Ishikawa-GFP (uterine origin) and MCF7-GFP (breast origin), displayed 
increased intracellular GFP intensity with estrogens. This system also responded in a 
tissue specific manner to selective estrogen receptor modulators. Raloxifene and 
tamoxifen were effective antiestrogens in MCF7-GFP cells, but acted as partial 
estrogen receptor agonists in Ishikawa-GFP cells at concentrations of 0.1 nM and 
above. Our results also showed no low dose synergistic effects between the tested 
estrogenic compounds.  
 
Physiologically realistic microCCA cell culture devices were designed and fabricated 
to help predict in vivo responses to EDs. The silicon microCCA device contained 
three cell lines for co-culture: HepG2/C3A (a hepatoma), MCF7-GFP and Ishikawa-
GFP to detect estrogens and address tissue specific effects of antiestrogens. 
Introduction and recirculation of medium mimic the time dependent changes in drug 
concentrations and the microfluidic shear situation inside a body.  In addition, an in-
line bubble trap was incorporated into the system to overcome air bubble related cell 
death and device failure in previous designs.  
 
Interactions between hydrophobic surfaces and the fluid are important in microCCA 
devices due to decreased fluid volume and increased surface area to volume ratio. 
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Significant surface adsorption of estrogen and several other hydrophobic chemicals to 
BPT tubing was observed with the peristaltic pumps for microCCA. Contaminants 
leaching out of the BPT tubing were also found to be estrogen receptor agonist, caused 
increased GFP expression in MCF7-GFP and Ishikawa-GFP, and interfered with the 
detection of estrogens. PTFE and stainless steel caused little interference. To 
overcome this problem, a PDMS based micropump was build to replace the previously 
used peristaltic pump. The benefits of the micropump are the replacement of BPT 
tubing with PTFE tubing, compact in size, small inner volume and the capability to 
allow parallel tests. Preliminary results indicated that the use of the micropump would 
overcome the GFP background problem associated with BPT tubing. Incorporation of 
the micropump with microCCA enabled the detection of cell response to estrogens.  
 
A major limitation of silicon microCCA devices is their fragility, need for extra 
housing to form close cell culture compartments, and possible cross contamination 
problems associated with reuse. In this work disposable PDMS microCCA devices 
were developed, and the main challenge of seeding multiple types of cells without 
using complex fluidic control and expensive controlling system was solved.  We 
developed a photopolymerizable hydrogel based method for direct patterning of 
Ishikawa, MCF-7 and HepG2/C3A cells into their individual cell culture chambers. 
Cells maintained excellent cell viability after UV polymerization.  The use of this 
device as a biosensor was demonstrated by monitoring viability of PEG encapsulated 
cells in microCCA exposed to a model reagent, Triton X-100. A 20 min exposure led 
to 100% cell death while 90% cells in control samples were alive. These results 
indicate the potential of photopolymerizable hydrogels to be used with PDMS 
microCCA devices to detect toxins, including environmental endocrine disruptors. The 
overall cost of PDMS microCCA device is also much lower than silicon microCCA. 
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6.2 Recommendations 
The mechanism or estrogen action involves multiple molecular pathways. The main 
molecular pathway is the ER-ERE pathway, which has been addressed in this study. In 
addition, the "ERα/AP-1 pathway" involves indirect recruitment of liganded ERαs to 
activating protein-1 (AP-1)-responsive DNA elements via heterodimers of Fos and Jun 
[1-3]. A retrovirus plasmid pQCXIP-AP1-GFP plasmid has been constructed, and cell 
infection has been finished. Further cell selection and characterization are necessary to 
build a responsive cell line. It would be important to test potential EDs with this cell 
line representing the ER-AP1 pathway as well. Other pathways may include cross talk 
between ER and other nuclear receptors, such as the aryl hydrocarbon receptor [4], or 
through disruption of cellular signaling cascades that interface with the hormone 
signaling systems. Further steps to address these and all other potential pathways are 
necessary for complete screening of EDs for their potential estrogenicity. It would be 
of great importance to study the mixture of EDs that act through different pathways to 
explore possible cocktail effects to human beings. Further, it would be interesting to 
develop assays to study androgenic EDs as well.  
 
In chapter 4 we described a microCCA experimental setup with a PDMS micropump.  
The fluidic pathways between microCCA and the pump were connected via tubing.  
One area for further development is to integrate the micropump with the microCCA 
device for an all-in-one device with a smaller size and for more reproducible and 
efficient pumping with less fluidic resistance and to avoid the use of tubing.  The 
hydrogel based PDMS microCCA platform described in chapter 5 is a key element 
that may enables this integration step as both are made from PDMS.  Though the 
micropump can deliver fluid continuously and precisely, their durability remains to be 
161 
 
improved. Surface adsorption of hydrophobic compounds is another concern in the 
study of with low chemical concentrations (1uM or less), which are usually true for 
hormones. 
 
In chapter 5, PEG was used at a model photopolymerizable hydrogel for cell 
encapsulation within microCCA.  The extreme hydrophilicity of PEG limited the long 
-term cell viability encapsulated within PEG due to limited cell-matrix interaction, 
which is important for endothelial cells to survive.   To solve this problem, PEG may 
be modified or mixed with adhesive peptides, ECMs or positively charged polymers to 
promote cell attachment to the PEG hydrogel structure, RGD modified PEG was 
reported to maintain cell viability for over a week[5]. It would be interesting to test 
alternative hydrogel materials, such as dextran AC, with different hydrophobicity. 
 
One more area worth further development is the construction of cell-seeded 
microCCA biosensors with long-term storage capabilities that are ready to use as 
needed. Current experimental setups require device preparation such as cell seeding 
and device assembly performed right before drug dosing, which is then followed by 
imaging and data analysis. However, an ideal way is to have devices readily available 
for dosing, as cell seeding and device assembly take hours of experimental setup time , 
and require professional skills,  PEG encapsulation provide extra protection during 
cryopreservation and it has been reported that cells entrapped in PEG hydrogel 
microstructures remained viable throughout the freezing process [6]. The concept of 
air-dry stabilization of mammalian cells with subsequent recovery following 
rehydration has also been demonstrated with Human 293H cells transfected with a 
cyanobacterial gene encoding sucrose phosphate synthase [7] . These techniques may 
potentially be used to provide stabilized mammalian cells for mammalian cell-based 
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biosensors with extended shelf lives.  The PDMS microCCA devices and the PDMS 
micropump, which have been described in chapter 4 and chapter 5 respectively,   
provide a feasible platform for fabrication of ready-to-use biosensors for applications 
in drug screening, pathogen detection and in the study of endocrine disruptor as well.  
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